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" This Trunk had been found in 
some Church-yard or Charnel-House, 
as appeared by its dark red Colour and dryness. "
" The Figure o f  this Trunk was crooked, making part o f  a circle, the Spine making 
the Convex and the inside o f  the Vertebrae the Concave part o f  the Segment. "
" The great difficulty seeming to be in the Respiration, 
how that could be performed when the 
Ribs were thus Immoveable "
Bernard Connor, 1695 1
An extract o f  his letter to Sir Charles Walgrave,
giving an account o f
" An Extraordinary Human Skeleton "
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SUMMARY OF CONTENTS
This thesis embraces a series o f  related studies spanning fourteen months. 
An initial questionnaire-based survey identified the presence o f  undue breathless­
ness perceived in a significant proportion o f  patients with ankylosing spondylitis 
(AS). The finding was substantiated by an oxygen-cost diagram study comprising 
matched healthy controls. Measurements o f  respiratory muscle strength and endu­
rance were made in a subsequent study. Although maximal strength o f  the respira­
tory muscles was preserved in the A S patients, their respiratory muscle endurance 
during work requiring high inspiratory pressures was clearly impaired. Upright 
symptom-limited exercise confirmed that exercise tolerance and aerobic power 
were commonly curtailed among the A S  patients. Relative to matched controls, 
ventilatory response and heart rate response to exercise in the A S patients were 
raised. However, the elevated ventilatory and heart rate responses were not 
accompanied by abnormalities in pulmonary gas exchange, breathing reserve, or 
other cardiocirculatory indices. Although the A S subjects perceived a higher 
degree o f  breathing effort fo r  an equivalent level o f  work rate or ventilation, they 
were not ventilatory limited. By contrast, the finding o f  a greater magnitude o f  
leg fatigue perceived among the A S subjects despite achieving a lower work rate 
strongly suggested a significant element o f  peripheral musculoskeletal decondi­
tioning. The elevated heart rate response was compatible with an element o f  
cardiac deconditioning secondary to a relative lack o f  physical activity.
Finally, the relative contribution ofpulmonary factors, chest restriction, 
and muscular function to the reduction in aerobic power among the A S  patients 
was quantitively examined. Peripheral muscle strength was found to exert the 
strongest influence on aerobic power in the A S patients. The addition o f  lean 
body mass further improved the variability explained by the regression model 
derived. No significant influence o f  impaired respiratory muscle endurance on 
aerobic power was observed. Vital capacity and limited chest expansion exerted 
only weak influences on aerobic power in the A S subjects.
The results from the studies comprising this thesis thus emphasise the 
importance ofphysical activity in this condition. Suggestions fo r  further 
interventions/strategies o f  clinical value were made.
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Chapter 1
1
Introduction and Review of the Literature
1.1 Ankylosing spondylitis : An Overview
Ankylosing spondylitis (AS) is the main representative of the clinical entities 
collectively coined seronegative spondarthritides. It is characterised pathologically 
by lesions described as enthesopathies,^ the inflammation o f ligamentous insertions. 
The discovery in 1973 of its strong relation to human leukocyte antigen (HLA) B27^ 
has greatly stimulated academic interest in the study of genetic^ and environmental 
fa c to rs ^  in causing the disease; however, the aetiology remains obscure.
The diagnosis of AS is based on clinical and roentgenographic features. 
Regardless of the criteria used, the presence of sacroiliitis is the sine qua non for a 
diagnosis of AS, but radiographically detected sacroiliitis may not be an early or 
obligate manisfestation of the disease. *0 
Prevalence
Epidemiological studies attempting to define the prevalence o f AS have 
suffered from a lack of easily applied diagnostic criteria. Nonetheless, clinical and 
radiographic studies from Britain* * and the Netherlands*2 gave an AS prevalence of
0.19 %  and 0.08 % respectively, among individuals older than age 15. Men are four 
to six times more commonly affected.
2Clinical manifestations
AS typically starts in adolescent men, with insidious onset of low back pain 
and stiffness. Although the axial skeleton is predominantly affected, any joint may be 
involved. Peripheral arthritis occurs in at least one third of all cases and may start 
many years after spinal disease. ^  Progressive ascending involvement o f lumbar, 
thoracic and cervical vertebrae leading to complete ankylosis and kyphosis is the 
extreme form of AS and occurs only in a minority of cases. ^  Figure 1.1 shows the 
typical posture of a patient with advanced AS.
Acute anterior uveitis is the most common extraskeletal involvement in AS 
and occurs in 20 to 40 %  of cases ^  at some time in the course of their disease.
Several forms of cardiac involvement are recognized. Aortic incompetence is the 
most characteristic lesion and, although occasionally severe, it is often asymptomatic. 
Conduction defects, arrhythmias and pericarditis are also well documented. More­
over, the development of noninvasive cardiac imaging techniques has raised the 
sensitivity in the detection of valvular^  as well as myocardial d isease^  in AS.
Involvement of the thoracic spine (including costo-vertebral joints) and enthe- 
sitis at costostemal areas and manubriostemal joints may cause chest pain. Rigidity 
of the chest wall is a hallmark of the disease. Pulmonary function impairment, one 
of the main issues of interest in this thesis, merits special review in section 1.5.
Pulmonary parenchymal involvement in AS is uncommon. A review of 
2,080 AS patients by Rosenow etafi%  disclosed 28 cases with pleuropulmonary 
diseases,the most common one being upper lobe fibrobullous lesions (an incidence 
of 1.25 %).
Rare complications which have been reported include amyloidosis of the AA 
type, igA nephritis, 19 and cauda equina syndrome.20 
Course and prognosis
AS generally runs a chronic and benign course but with a risk, in a minority 
of cases, o f handicap and life-threatening complications, e.g. atlantoaxial joint sub­
luxation,21 acute fulminant aortic d isease^  etc. Progressive impairment of spinal 
mobility occurs in half the cases or more, however, functional outcome is often 
satisfactory.23 The early presence of peripheral joint disease, iritis, pulmonary
fibrosis, and persistently high sedimentation rate is indicative of a poor prognosis. 14 
Excess mortality in A S  in early reports is primarily ascribed to complications 
of radiotherapy and a m y l o i d o s i s . 24,25 Although a shorter life span has also been 
observed among nonirradiated men with A S , 26,27 thjs is most likely a result o f the 
impact of referral bias producing patients cohorts with more severe disease. It is
likely that survival of patients with mild disease who form the majority of cases is 
comparable to that of general population.28 
Management
The importance of physical therapy in AS cannot be overemphasized. While 
treatment with nonsteroidal anti-inflammatory drug (NSAID) is effective in reliev­
ing pain and possibly minimizing stiffness, disease modifying agents are, to date, not 
available in AS. Sulphasalazine is used for patients with peripheral arthritis but no 
lung function studies have been done on patients treated with this drug. In a study29<>n 
lung function in 33 AS patients receiving NSAID for 12 weeks, there was no change
4in vital capacity (VC) during a follow-up period of 48 weeks. The result from this
study suggests that NSAID therapy does not influence lung function or, alternatively, 
VC is not an appropriate outcome measure of short term therapy in AS.
The goals of physical therapy are to relieve pain and maintain functional capa­
city by a daily exercise programme. Knowledge of the mechanism(s) underlying 
exercise limitation in AS patients is thus needed in order that rational physical train­
ing can be formulated tailored to individual abilities.
However, little is known about the factors influencing exercise capacity in AS 
and the mechanism(s) responsible for effort intolerance among AS patients remains 
poorly defined.
Hence, the focus of the present series of studies is the factors influencing 
exercise power among patients with AS. The following are an overview of exercise 
physiology and reviews on the areas pertinent to the the focus of this thesis, namely, 
exercise limitation, pulmonary function abnormalities, exertional dyspnoea, and 
respiratory muscle performance among AS patients.
1.2 Physiology of exercise
The conversion of stored energy into physical work is the function of the 
skeletal muscles. Energy for muscular contraction is obtained predominantly by the 
oxidation of fuel in the mitochondrion. This energy is used to form high-energy 
compounds, mainly creatine phosphate and adenosine triphosphate, from which 
energy can be made available for cellular reactions involved in systhesis, active 
transport and muscle contraction. 30 Thus, exercise entails an increased utilization
of O2 , to be matched by increased delivery of O2  from the atmosphere to the mito­
chondrion and the simultaneous removal of CO2 , the major end product of exercise.
These needs of cellular (internal) respiration of muscles can only be met by 
complex interactive systems providing gas exchange between the muscle cells and 
the atmosphere (external respiration)(Fig. 1.2 ). These systems comprise^ 1 
1) efficiently operating lungs and chest bellows, 2) an effective pulmonary circula­
tion through which the regional blood flow is matched to the appropriate ventilation, 
3) a heart capable of pumping the quantity of oxygenated blood necessary to sustain 
tissue energy exchange processes, 4) an effective circulatory system that can 
distribute blood flow to match tissue requirements, 5) blood with an adequate 
haemoglobin concentration, and 6) respiratory control mechanisms capable of 
regulating arterial blood gas tensions and pH.
This metabolic-cardiocirculatory-ventilatory coupling system has large func­
tional reserves so that there may be a wide variation in loss o f function before symp­
toms are e x p e r i e n c e d .  3  2  A  subject may perform daily activities quite normally with 
resting physiological variables in the normal range, and yet present with an effort 
tolerance more limited that most of his fellows. The relative subtle loss of function 
in this scenario may only be detected by measuring various physiological variables 
during exertion. Exercise testing thus provides a sensitive means both for assessing 
symptoms and for quantifying functional impairment.
1.3 Measurements during exercise testing
The development of rapidly responding O2 and CO2  analysers and computer-
assisted data processing have led to a broader application of cardiopulmonary 
exercise testing (CPX).33 CPX allows simultaneous measurement during known 
exercise stress of the following :
1. Aerobic uptake (VO2 ), expressed in terms of capacity (total energy output), 
or power (energy output per unit of time). Maximal O2  uptake attained for a given 
form of exercise (V0 2 max) is highly reproducible such that it has been regarded as 
an international reference standard of cardiorespiratory fitness by the World Health
Organization. 34
2. Respiratory variables, namely, a) breathing frequency (f), b) tidal volume 
(V j) and minute ventilation (Vg), and c) arterial blood gases measured directly with 
an indwelling arterial cannula or noninvasively with a combined O2  and CO2  trans- 
cutaneous electrode.35
3. Cardiocirculatory variables comprising : a) heart rate, b) blood pressure, 
and c) cardiac rhythm and pattern by an electrocardiogram. In addition, O2  pulse, 
which is the volume of O2  extracted by the peripheral tissue per heart beat, can be 
derived from AVO2 /AHR. It can also be considered an index of stroke volume.
4. Anaerobic threshold (AT), which is the level of VO2  above which aerobic 
energy production is supplemented by anaerobic mechanisms. As exercise
increases above a certain work rate, the oxygen required by the exercising muscles 
cannot be totally supported by O2 delivery, anaerobic processes meet this demand
1
by converting pyruvate to lactate.3b This is accompanied by an almost equal
reduction in bicarbonate concentration in the blood, causing CO2  production to 
accelerate. 3 ^ AT has been used as an effective gauge of physical fitness and a low
AT implies impairment of O2  delivery to the exercising muscles. It can be detected 
by measuring blood lactate level. More recently, Beaver e ta l 3% has developed a 
noninvasive means for detecting AT referred to as ' V-slope ' method. This uses 
computerized regression analysis of the slope of VCO2  vs VO2  plot, which detects 
the beginning of the excess CO2  output generated from the buffering of [H+].
Figure 1.3 shows an example of AT of a patient with AS detected by this method 
during CPX testing.
5. Other variables obtained include CO2  production (VCO2 ), and 
respiratory exchange ratio (R)(derived from VCO2 /VO2 ). Furthermore, cardiac 
response (AHR/AVO2 ) ventilatory response (AVCO2 /AVE) to exercise may 
also be derived.
These variables follow a predictable pattern in response to exercise so much 
so that measured deviations in the various relationships can pinpoint with remarkable 
accuracy which component of the system is at fault.
1.4 Exercise limitation among AS patients
Scanty data exist on exercise performance among sufferers from ankylosing 
spondylitis (AS). Renzetti et is credited for first studying gas exchange at rest 
ind after' a standard exercise test 'in  12 AS subjects. Mild arterial oxygen desatu- 
lation at rest (mean 94.9 %) and after exercise (94.7 %) was noted in half the group. 
However, it is unknown whether the gas exchange abnormality reported contributed 
t> exercise intolerance in this group of subjects. Furthermore, the method of 
exercise test employed was not cited.
It was not until 1985 when attention was paid to a formal assessment of 
cardiorespiratory response to exercise in AS patients. Elliott et al,40 in a study
comprising 6 AS subjects and 6 age-matched controls, observed a significant 
reduction in exercise capacity in the AS group. This exercise limitation was ascribed 
to deconditioning or cardiovascular impairment. Owing to the small sample size, 
the authors highlighted the need for more observations to further elucidate the 
mechanism underlying effort intolerance in this condition.
The latest work in the English literature in this field came from Fisher et a lM  
This study reconfirmed the exercise intolerance in 33 AS subjects studied and noted 
a correlation between vital capacity and V02max. However, this study did not seek 
to explore the factor(s) causing exercise limitation in AS.
Thus, while general physical therapy and rehabilitation programme has been 
well established for sufferers from AS, an understanding of the factors underlying 
exercise intolerance in this condition is far from complete.
1.5 Pulmonary function in AS
Rigidity of the thorax in ankylosing spondylitis (AS) was first recognized as 
long ago as 1695, when Bernard Connor 1 described a skeleton showing the charac­
teristic rigidity of the thoracic cage and lumbar spine and remarked that respiration 
must have been greatly restricted during life of the unfortunate sufferer. This astute 
observation remained unique until 1877, when Hilton F a g g e ^ 2  reported on the 
ankylosis o f the ribs with vertebrae.
Lung volume and subdivisions
The recognition of abnormalities in lung volumes in AS originated from the 
reports in the 1940s. Hart et al^observed  a reduction in vital capacity (VC) in 1 8  of 
2 1  AS patients, the mean VC being 79 per cent predicted. Subsequent r e p o r t s 4 4 - 5 1  
corroborated this finding, although the degree of reduction in VC and total lung 
capacity (TLC) varies from mild to moderate. Opinion is divided, however, over the 
effect of AS on residual volume (RV) and functional residual capacity (FRC). Some 
i n v e s t i g a t o r s 4 5 - 4 8  reported an increase in RV and/or FRC, while o t h e r s 4 9 - 5 1 found 
these to be normal. Conflicting data are also noted on the ratio RV/TLC. These 
discrepancies results from difference in stage of the disease and, to a greater extent, 
difference in reference values used. Furthermore, when relating measured values to 
predicted values, some observers used predisease h e i g h t ^ , 4 8 , 51 whilst others used 
actual h e i g h t , 45 not taking into account the flexion deformity caused by the disease. 
A review of lung volumes in AS from some of the previous reports is presented in 
Table 1.1.
The size of RV is important in understanding the disorder of the mechanics of 
respiration in AS. The finding of increased RV45-48 suggests that ankylosis o f the 
thoracic cage occurs with the ribs in a position of partial inspiration, the increase in 
RV and FRC being a consequence of a rise in the resting expiratory level.
Thoracic and lung compliances
Previous studies consistently found lung compliance to be n o r m a l , 5 2  
total thoracic compliance to be r e d u c e d 4 7 , 5 1 , 5 2  [n AS. These findings, in 
conjunction with the finding of normal diffusing c a p a c i t y 4 9 , 5 0  h a v e  led to the
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premise that the restrictive ventilatory defect in AS is consequent to limitation of 
chest expansion rather than intrinsic pulmonary parenchymal d i s e a s e . ^ , 49,50 
Pulmonary gas exchange
Previous reports on pulmonary gas exchange in AS gave divergent results.
In a study of 12 patients, M i l l e r & S p r o u l e ^  observed normal alveolar-arterial oxygen 
pressure difference, and normal physiological deadspace-tidal volume ratio. These 
findings are in contrast with those of Renzetti et who reported increased 
physiological dead space and significant arterial oxyhaemoglobin desaturation at rest 
and on exercise in most o f the 12 subjects studied. The authors postulated that the 
spondylitic process led to a relative decrease in ventilation in the upper part o f the 
lung whereas increased diaphragmatic excursions caused a relative increase in 
ventilation in the lower lung regions. Studies on regional ventilation in AS have shown 
conflicting results,however. Using krypton 8 l m washout, Parkin et a f i4 found no 
significant difference in regional lung ventilation between 27 AS and 18 controls.
By contrast, Stewart et observed a reduction in inhaled xenon reaching the lung 
apices but normal xenon perfusion in 9 AS subjects and invoked a relative impairment 
of apical ventilation in AS. Whether the possible reduction in ventilation to the lung 
apices of these isotope gases is of clinical importance remains speculative.
1.6 Exertional dyspnoea among AS patients
Dyspnoea is a cardinal manifestation of diseases involving cardiorespiratory 
systems. There is no universally accepted definition of dyspnoea, but it can be 
regarded as "difficult and uncomfortable b r e a t h i n g " 8 3  0r "the necessity for increased
respiratory e f f o r t ” . g4
A unitary explanation for the sensation of dyspnoea does not exist. The source 
and mechanism of exertional dyspnoea are most likely multifactorial. Increased 
respiratory muscle tension^and altered resting lung volum es^are among the factors 
which have been proposed as contributing to the sensation of increased breathing 
effort in different patients. It follows that patients with ankylosing spondylitis (AS) 
may perceive relatively higher intensity of breathing effort on the basis of impaired 
thoracic mechanics and altered lung volumes. The prevalence of dyspnoea on 
exertion among AS patients has, however, received little attention.
Although numerous studies have examined lung function indices in AS,43-55 
the effect of impaired lung volumes on the sensation of breathing in AS patients is 
little known. Furthermore, the impact o f exertional breathlessness (if any) among 
patients with AS on effort tolerance remains unclear.
It is widely believed that AS patients rarely experience respiratory 
s y m p t o m s , 41,45,46aithOUgh in one rep o rt^  4 of the 8 AS patients studies perceived 
dyspnoea on exertion. The symptoms may be masked by the more striking spinal 
pains which so predominate the clinical picture and render exertion difficult and 
exertional dyspnoea impossible in most cases.
Nonetheless, complaints such as " I cannot fill my lungs properly " ;
” My chest feels stiff ” ; or " I  cannot exert m yself" are not uncommon among 
AS sufferers.56
1.7 Respiratory muscle performance
As outlined in section 1.2, the performance of respiratory muscles, pivotal to 
the efficiency of chest bellows, is an important part of the complex systems provid­
ing adequate gas exchange during exercise and, indeed, at rest. Assessment of 
of respiratory muscle function thus forms an essential part o f any comprehensive 
evaluation of exercise tolerance. The following are a review of the structure and 
function of respiratory muscles, methods of assessment, and the current knowledge 
on respiratory muscle performance in patients with AS.
Structure and function
The respiratory muscles consist primarily of the diaphragm, the intercostal, 
abdominal and accessory muscles. The diaphragm is the principal muscle of 
inspiration. It consists o f two parts, the costal diaphragm, originating over the inner 
surface of the six lowest ribs, and the crural portion, which arises from the second to 
fourth lumbar vertebrae.57 Contraction of the diaphragm has several effects result­
ing in inspiration. The central dome descends causing a decrease in pleural pressure 
and an increase in lung volume. This produces the rise in abdominal pressure, 
causing the anterior abdominal wall to move outwards. The costal fibres, using the 
abdominal contents as a fulcrum, act to lift the lower rib cage. The intercostal 
muscles play an important role in stabilizing the rib cage, preventing paradoxical 
inward motion of the rib cage during inspiration.58 The accessory muscles, 
comprising mainly the scalenes and stemomastoids, also help stabilize the upper
13
The mechanics of the thoracic cage, including the vertebrae, is therefore an 
important determinant of the chest bellows function. Each thoracic vertebra has 
eight articular surfaces : the right and left costo-vertebral and costo-transverse, the 
right and left intervertebral articular facets superior and inferior. Considering the 
involvement of these joints throughout the thorax with gradual bony fusion, soft 
tissue shrinkage and calcification, it is not surprising that thoracic expansion is 
greatly diminished in advanced AS. Such a complete picture, however, does not 
always occur and does not necessarily parallel changes elsewhere in the b o d y . ^ 6  
Nonetheless, these changes render the vast majority o f AS patients heavily dependent 
on their diaphragm.
Assessment of respiratory muscle strength
The simplest approach is to measure inspiratory and expiratory pressures at 
the mouth with the subject performing maximal efforts against a closed airway (MIP 
and MEP, respectively). The most widely used technique is that described by 
Black & Hyatt.^9 The only equipment needed is a tube connected to aneroid 
pressure gauges. In order to minimize the pressure generated by the facial muscles, 
a small air leak is created at some point in the tubing circuit so that the additional 
pressure generated in the mouth can dissipate. More recently Hamnegard e t  a l  
has shown that a microcomputer-based mouth pressure meter (to be described in 
details in chapter 3.2) provides reliable and accurate MIP and MEP measurements in 
normals as well as in patients with respiratory disorder. This equipment is robust and 
portable and should play an important role in providing respiratory muscle evaluation 
as a research and clinical technique.
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The lengths of the respiratory muscles and therefore their contractile forces, 
vary with lung v o l u m e s . 62 The expiratory muscles are longer and nearer to their 
optimal resting length (L0) at high lung volume. Conversely, the inspiratory muscles 
are longer and nearer to their L0 at low lung volume. Accordingly, MIP is measured 
at FRC or RV and MEP at TLC.
Respiratory muscle pressures may also be recorded within the pleural and 
abdominal cavities by means of oesophageal and gastric balloons. The nature o f the 
test and the procedure involved are, at best, unpleasant to the subject, thereby render­
ing their clinical applications limited.
Normal values for maximal respiratory pressures
The usefulness of maximal respiratory pressures (MRP) has been obscured by 
the remarkably large between-studies variability in the l i t e r a t u r e . 59*63-66 Reference 
values for MRP from some of the prominent studies are summarized in Table 1.2.
For instance, Black and Hyatt59 reported a mean MIP of 124 ( SD 22) cmH20 in 
men of 20-54 yrs of age whereas a mean of 106 (SD 31) cmH20 was quoted for men 
of 19-65 yrs of age by Wilson et afo3 despite employing similar apparatus. An even 
more remarkable difference is found in the MEP values quoted in the two studies.
Such discrepancies might be linked to several factors including the differences in the 
population sizes, in the techniques used, in the number of efforts p r o d u c e d , 6 7 , 6 8  
and in the types of mouthpiece u s e d . 69 
Respiratory muscle endurance and its measurement
Unlike other groups of skeletal muscles, the respiratory muscles operate conti­
nuously throughout life. Respiration is thus an endurance effort. In conjunction with
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isolated peak pressures, assessment of respiratory muscle performance in terms of 
endurance could therefore provide further insight into its efficiency.
The direct tests o f respiratory muscle endurance (RME) are based on the capa­
city of the respiratory muscles to generate and sustain high levels of pressure. The
high pressures can be achieved by means of either inspiratory resistive load^O* 71 or 
inspiratory threshold l o a d . 72 in the former method, subjects breathe through inspira­
tory resistance of varying magnitude. The latter involves inspiring through a device 
that contains a weighted plunger, for example. A sufficient inspiratory pressure 
must be generated to lift the plunger out of its socket.
Regardless of the type of load employed in RME testing, the breathing pattern 
must be standardized so that airflow does not vary. Bellemere & G r a s s i n o , 7 3  in a 
study on 4 male volunteers, found that intense diaphragmatic contractions of brief 
duration could be sustained for as many breaths as could less intense contractions 
that occupied a larger fraction of total breath time. Based on the data from that study, 
they proposed tension-time index of the diaphragm (TTIdi). TTIdi is the product of 
contractile force and duration, where force is expressed as the ratio o f transdiaphrag- 
matic pressure (Pdi) to maximum Pdi, and duration is expressed as duty cycle. Duty 
cycle is the ratio of inspiratory duration (Ti) and total breath duration (Ttot).
Endurance time (Tlim) could be related to TTIdi by the expression: Tlim = 0.1 (TTIdi)"3-6 
which is valid when TTIdi is in excess of 0.15. It predicts that TTIdi of 0.15 would 
cause diaphragmatic fatigue in approximately 1.5 hours whereas TTIdi o f 0.3 would 
produce fatigue in less than 10 minutes.
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Respiratory muscle performance patients with AS
It is well established that diaphragmatic contribution to tidal breathing is 
increased in AS patients,74-75 implying functional insufficiency of the rib-cage 
muscles in this condition. However, quantitative data on respiratory muscle 
strength (RMS) and endurance (RME) in AS is scarce.
In a study of 30 patients with AS, Vanderschueren et a fl^  found that 16 of the 
patients had MIP of two standard deviations or more below the mean of the normal 
values of A r o r a . 6 6  Furthermore, 27 of these patients were reported to have MEP of 
two standard deviations or more below the mean of the normal values. These led to 
the conclusion that RMS in patients with AS was clearly reduced.
This notion has remained, to date, unchallenged. On the one hand, it seems 
plausible considering that the impaired thoracic cage mechanics may render the rib- 
Ccge muscles anatomically disadvantageous. On the other hand, it is contradictory 
to the observation that the diaphragm, the principal muscle of respiration, compensates 
well in AS.74-75 The crux of the matter may lie in the reference values for MRP 
u<ed in the above-mentioned study. Given the inconsistency among the reference 
vdues in the literature (Table 1.2), a different conclusion may have been drawn from 
this study if  the MRP values had been related to reference values from other sources.
Furthermore, the effects of altered lung volumes and chest restriction on RMS 
ard RME in AS are unknown as is the influence of impaired RMS and RME (if any) 
oi exercise tolerance in this condition.
Thus, further studies in this field are needed and studies comprising matched 
controls would be preferable.
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1.8 Peripheral muscle strength
Also crucial to exercise performance is the strength of exercising muscles. 
Indeed, exercise tolerance is normally dictated by skeletal muscle fatigue related to 
lactic acid accumulation which results from anaerobic m e t a b o l i s m .  7 7  In a study of 
200 patients with chronic airflow limitation, Allard et observed a significant 
reduction in peripheral muscle strength (quadriceps and handgrip), which contributed 
significantly to work capacity independent of the lung function indices.
Although convincing evidence of involvement o f skeletal muscles in AS is 
lacking, 79ft is conceivable that peripheral muscle deconditioning, by virtue o f disuse, 
may limit exercise performance in this condition. Research into this area is hence 
needed. Should deconditioning prove to be an important factor limiting exercise 
among AS patients, strategies for improving peripheral muscle strength and/or endu­
rance might be directly beneficial as has been shown in, for example, patients with 
chronic airflow limitation. 80
1.9 Aims of the present studies
Based on the foregoing, the aims o f the present studies are as follows :
1) To evaluate respiratory muscle strength (RMS) and endurance (RME) in 
AS patients.
2) To assess the possible effect(s) of altered lung volume and subdivisions 
and chest restriction on RME and RMS in AS patients.
3) To systematically evaluate the degree of perceived exertional dyspnoea 
and its possible relation with chest restriction and altered resting lung 
volumes in AS patients.
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4) To comprehensively examine the cardiorespiratory response to exercise 
in AS patients.
5) To comprehensively examine the mechanism(s) responsible for exercise 
limitation in AS patients.
6) To identify and determine the individual and additive influence of the 
magnitude of chest expansion, lung volume, respiratory muscle strength 
and endurance, peripheral muscle strength, and body composition on 
exercise power among AS patients.
1.10 Plan and study design
The studies comprising this thesis attempted to address well defined, pre­
specified questions. It was considered desirable to commence the project with a 
questionnaire survey on a group of patients with AS attending a tertiary rheumato­
logy clinic (chapter 2). This strategy served to provide a broad picture of respiratory 
symptoms among the patients and to identify willing subjects. The studies then 
proceeded with assessment of respiratory muscle performance, evaluation of 
exertional dyspnoea and cardiorespiratory response to exercise and, finally, an 
analysis of factors influencing exercise power in the subsequent chapters.
In view of the large variability among reference values for some of the 
variables measured, a group of age-and gender-matched controls were also recruited 
for comparative studies. This was the case for the assessment o f respiratory muscle 
performance and the evaluation of perceived exertional dyspnoea.
Sample size determination
In order to achieve significant quanta of analytical power, the required sample
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size was predefined, where possible. For example, the required sample size for the 
study on respiratory muscle performance (chapter 3) was estimated prior to the study, 
utilizing the nomogram proposed by Altman** 1 (fig 1.4).
Statistical methods
The appropriate statistics employed were planned in the formative stages.
Values are presented as mean (SD) or (SEM), or mean (95% Cl) as appropriate.
As Normal distribution was not assumed for many variables studied, nonparametric 
statistics were used to assess differences between controls and AS subjects with 
respect to various physiological variables. The magnitude of linear association 
between pairs of continuous variables was measured with product moment correla­
tion coefficients. The mean values o f various measurements were considered 
significantly different when the probability of the difference of that magnitude, 
assuming the null hypotheses to be correct, fell below 5 % (i.e. p < 0.05). As in 
other explanatory studies, it is sometimes unavoidable to perform multiple compa­
risons or significance testings, the bonferroni correction was applied to avoid type I 
e r r o r . Forward stepwise regression analysis was used to determine the additive 
influence of various parameters on exercise power (chapter 5). A standard statistical 
software ( MINITAB, release 9.2, Minitab Inc., PA, USA ) was used for all statistical 
analyses. Fisher's exact test, employed in chapter 2.2.1, was performed by a special 
macrofile of MINITAB, by courtesy of the Robertson Centre for Biostatistics, 
University o f Glasgow. The statistics used were further specified in the respective 
chapters.
2 0
Summary
An overview of ankylosing spondylitis (AS) and physiology of exercise have 
been presented. While a great deal of data on lung function abnormalities in AS are 
available, little is known about the impact of these abnormalities on the sensation of 
breathing and on exercise power in this condition. Limited information on respiratory 
muscle performance in AS exists and the contribution of the possible impairment in 
respiratory muscle strength and endurance on exercise limitation in this condition 
remains unknown. Although previous studies have consistently shown that exercise 
intolerance is common in AS, understanding of the influence of cardiocirculatory, 
respiratory as well as peripheral muscular factors on exercise performance in this 
condition is incomplete. Finally, aims of the present studies have been proposed 
and plan and study design described.
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Figure 1.1 Typical posture o f  a patient with advanced ankylosing spondylitis, 
illustrating forward flexion, thoracic kyphosis, and loss o f  lumbar 
lordosis.
( With kind permission from  the patient)
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Figure 1.2 A scheme illustrating the gas transport mechanisms fo r  coupling 
cellular (internal) to pulmonary (external) respiration. The gears 
represent the functional interdependence o f  the physiological com­
ponents o f  the system. The increase in O2  utilization by the muscles 
(Q°2) is achieved by increased extraction o f  O2  from the blood 
perfusing the muscles, an increase in cardiac output, an increase in 
pulmonary blood flow, and finally, an increase in ventilation.
( Reproduced with written permission from the authors 31)
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Figure 1.3 Anaerobic threshold (AT) o f  a patient with ankylosing spondylitis, 
determined by the ' V-slope ' method during a cardiopulmonary 
exercise testing. A T  is identified as the breakpoint (arrow) in 
the CO2  output vs O2  uptake plot.
This subject's predicted V 02^ca  was 2.15 L min~l.
The A T  = 1.17 Lmin~I (55  % pred. V02max).
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Figure 1.4 Nomogram fo r a ftw-sample comparison o f  a continuous variable, 
relating power, total study size, the standardized difference, and 
significant level
( Reproduced with written permission from the author )
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Table 1.1
Review of the literature on lung volume and subdivisions 
in patients with ankylosing spondylitis.
Reference
num ber
Number of 
subjects
VC FRC RV TLC RV/TLC
44 35 i N N I t
45 16 i n t t N t
46 53 i t t N NM
47 22 u t t I NM
48 17 4- t t NM
49 38 I NM N t
50 32 I N N N N
51 16 I N N I t
Abbreviations and symbols : N = Normal
NM = Not mentioned 
i  = Lower than predicted values 
'lir = Markedly lower than predicted values 
f  = Higher than predicted values 
t t  = Markedly higher than predicted values
Table 1.2
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Review of the literature on the reference values for maximal 
static respiratory pressures in normal population.
Reference
num ber
Gender Age 
( r ange )
Sample
size
MIP 
( cm H 20 )
MEP 
( cm H 20 )
59 Male 20-54 60 124 (22) 233 (42)
63 Male 19-65 48 106 (31) 148 (34)
64 Male 18-83 100 130 (32) 237 (46)
65 Male 18-70 326 119(36) 139 (30)
66 Male 19-49 80 127 (28) 216(45)
59 Female 20-54 60 87 (16) 152 (27)
63 Female 18-65 87 73 (22) 93 (17)
64 Female 18-83 100 98 (25) 165 (30)
65 Female 18-70 423 83 (30) 95 (20)
66 Female 19-49 121 91 (25) 138 (39)
Abbreviations : MIP = Maximal static inspiratory pressure ;
MEP = Maximal static expiratory pressure.
NB. MIP and MEP values are expressed as mean (SD).
Although MIP is in fact a negative value with respect to ambient pressure, 
it is reported here as a positive value for clarity o f presentation.
Chapter 2
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Exertional Dyspnoea among AS Patients : Prevalence
2.1 Introduction
As dyspnoea is one of the principal symptoms limiting effort tolerance among 
patients with various conditions, an investigation into the prevalence of dyspnoea on 
exertion is an appropriate first step for studies on exercise limitation. For a clinical 
entity in which the prevalence of the symptom concerned is little known, a question­
naire represents a useful tool which enables clinical information to be obtained from 
a large number of patients.
Accordingly, the studies comprising this thesis commenced with a medium 
scale questionnaire-based survey with an emphasis on exertional dyspnoea in a group 
of patients with ankylosing spondylitis (AS) attending a rheumatology clinic with a 
large pool o f patients with this condition.
This strategy served a number of purposes, namely :
1 to obtain a broad picture of respiratory symptoms as well as other clinical 
information of interest among AS patients.
2 to estimate the prevalence of undue exertional dyspnoea in AS patients.
3 to compare the frequency of undue breathlessness between patients classed 
as exercisers/non-exercisers and smokers/non-smokers.
4 the clinical information obtained would be used in the subsequent studies.
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5 the patients willing to participate in the subsequent physiological studies 
would be identified.
2.2 Questionnaire survey
The problems in obtaining and utilising data from medical questionnaires have 
been discussed in a series of articles by Wright & Haybittle,87 and a number of 
factors were considered in the design of the questionnaire.
a) General design
The questions were kept as simple as possible with the answers mainly " Yes " 
or " No ", and the replies consisted of ticks to appropriate boxes to minimise error in 
completion. The form was designed to be completed in about 10 minutes. The draft 
questionniare was tested on an initial 10 patients and their comments sought before 
finalising the format.
b) Form-filling
Some difficulties are commonly encountered with a self-completed question­
naire. The questions are sometimes misunderstood and contradictory answers given. 
Unsatisfactory replies are often obtained for questions requiring numerical details, 
e.g. amount of cigarettes smoked per day, number of hours spent for sports or 
exercises per week etc. In order to minimise these problems, the questionnaires used 
in this study were completed in a direct interview.
c) Content
The full questionnaire is detailed on Appendix A. It was orientated to respira­
tory symptoms and was simplified from the standard questionnaire designed by the
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Medical Research Council committee. 88 The information concerned the following 
topics : question 1 Duration of the disease, since the symptoms started
questions 2-3 Level of physical activity 
question 4 Undue breathlessness 
questions 5-8 Chronic cough or sputum production 
questions 9-12 Smoking habit 
questions 13-14 Background medical history 
questions 15-16 Tiredness and physical fitness
2.2.1 Study population and methods
This questionniare survey was conducted during May-July 1993 by the inves­
tigator ( P Riantawan ) in a tertiary referral seronegative arthropathy clinic( Glasgow 
Royal Infirmary ), Consecutive patients with definite AS ( modified New York 
criteria^) were interviewed. Since no previous quantitative data regarding breath­
lessness in AS existed, the required sample size could not be prespecified with 
confidence. Nonetheless, it was considered necessary to obtain data from at least 
60 subjects. For question 4 (undue breathlessness), the interviewees were asked 
specifically to focus on the difficult and uncomfortable breathing and not vague 
chest discomfort or rib pains.
Statistical methods
The frequency of various symptoms are presented as per cent. Analyses of 
the differences in the frequency of various symptoms between exercisers/non­
exercisers and smokers/non-smokers were performed, using Chi squared test or
Fisher’s exact test, as appropriate. For the purposes o f this study, exercisers were 
defined as the subjects who regularly took exercise or played sport on a weekly basis 
Smokers were defmed as current smokers or ex-smokers of > 5 pack yrs. 
Non-smoker category comprised never-smokers and ex-smokers o f < 5 pack yrs. 
Statistical significance was assessed at 5 % level.
2.2.2 Results
A total o f 62 AS patients were interviewed ( 47 male, 15 female; mean age 
46.8, SD 10.3 yrs ). The frequency of symptoms and information o f interest is 
presented in Table 2.1. Undue breathlessness was reported in 26 %  of the subjects. 
Chronic cough and sputum production were noted less commonly, 16 % and 13 % 
respectively. 47 % of the patients were classed as exercisers and 61 % as smokers. 
25 patients (4 0  % ) were ex-smoker of > 5 pack yrs. whereas 13 patients ( 21 % ) 
were current smokers. Not unexpectedly, tiredness and worsened fitness were 
reported in 72 % and 64 %.
Tables 2.2 a) and b) compare the proportions of the patients reported undue 
breathlessness with respect to exercise and smoking habits. The frequency of this 
symptom was significantly lower among exercisers (%2 = 4.107, p = 0.04). The 
proportion was however not significantly different between smokers /  non-smokers
(X 2 =  1.708, p = 0.18).
Tables 2.3 a) and b) compare the proportions of chronic cough and sputum 
production between smokers and non-smokers. At 5 % significant level, the two
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groups did not differ in the frequency of these symptoms (p = 0.12 and 0.64, respec­
tively).
2.2.3 Discussion
Clinical studies within the confines of academic centres may suffer from 
biases inherent in the study of referral patients. The best patient population would 
be a group of individuals randomly selected from the range of referral centres, 
general hospitals and general practitioners. In addition, those who are not followed 
by the medical profession would be of interest. Clearly, this ideal population does 
not exist. Furthermore, definitive survey on a large scale community-based study 
would be an almost, if  not, impossible task.
The questionnaire employed in this survey, like other clinical questionnaires, 
is not infallible. The chronic respiratory questionnaire (CRQ)^^, which comprises 
four clinical dimensions, has recently been reevaluated and the dyspnoea dimension 
found to be u n r e l i a b l e . 9 0  The well established questionniares orientated towards 
arthritic problems, for example the arthritis impact measurement scale,^1 do not 
directly address dyspnoea. Although formal piloting was not carried out, the draft 
questionnaire was tested on the initial 10 subjects before finalising the format. Most 
importantly, undue breathlessness, the main focus of the survey was carefully 
defined to all the interviewees.
The finding of undue breathlessness in 26 % of the AS subjects interviewed 
contrasts with the prevailing concept that respiratory symptoms are rare in this 
condition.^1,45,46 This symptom was not directly linked to tobacco smoking,
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suggesting that other factors, rather than airways disease are at play. This served to 
indicate the need for subsequent physiological studies (chapters 3-5).
The overall prevalence of smokers among the AS patients interviewed (61 %) 
was rather high, as compared to that of general population in the U.K. ( 30 - 35 % ).92 
Nevertheless, the majority were ex-smoker, and only 21 percent were current smokers. 
The anticipated association between smoking habit and chronic cough and sputum was 
not confirmed at 5 % significant level. The most likely explanation seems to be the 
relatively small sample size; nonetheless, the raw data suggested that smokers were 
more commonly affected by these symptoms. The interview replies therefore did not 
seem to have been subject to inconsistency or major distortion.
The relatively high prevalence of feelings of tiredness and worsened fitness 
observed in this survey is not unusual in AS. This finding underpins the demand for 
strategies to help maintain physical fitness among sufferers from this condition.
2.3 Oxygen-cost diagram study
The initial survey suggested that undue breathlessness was not uncommon 
among sufferers from ankylosing spondylitis (AS). However, assessment o f dysp­
noea based on questionnaires suffers from two major limitations. The intensity of 
dyspnoea cannot be defined in quantitative terms by using a questionnaire.Moreover, 
comparative studies are not feasible. The latter is of clinical importance considering 
the subjective nature of dyspnoea; therefore, studies comprising control subjects 
would yield a better precision as to the presence of heightened perception of breath­
ing effort among the patient population concerned.
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Dyspnoea, like other sensations, can be quantified by the use of visual ana­
logue scales (VAS).93 VAS is a straight line representing the continuum from no 
effort to maximum effort perceived; the subject indicates the point on the line which 
he judges to represent his sensation.
Hence, a further appraisal of dyspnoea among AS patients was made in a 
study comprising matched controls using an Oxygen-cost diagram (  vide infra).
2.3.1 Study population and methods
Subsequent to the initial survey, a group of patients with definite AS were 
invited to participate in the further studies. The recruitment was carried out with no 
reference to the presence of respiratory symptoms, or exercise/smoking habits. The 
invitation was met with enthusiastic supports, although many could not participate on 
account of travel difficulty, or being too physically limited. Furthermore,in order to 
minimise confounding factors, exclusion criteria were necessarily applied as follows:
1) patients with a history of cardiac disease or taking p-blocking agents, 2) patients 
with previous exposure to radiation, asbestos or drugs associated with pneumonitis,
3) patients with chest pain on deep inspiration affecting performance of various breath­
ing manoeuvres in the subsequent studies, and 4) patients with significant pain in the 
hip, knee or ankle joints or with hip replacement precluding optimal performance on 
cycle ergometry (chapter 4 & 5).
A total of 20 patients participated in the present study. 20 age-and gender- 
matched healthy volunteers served as a control group. Clinical characteristics of the 
two groups are summarised in table 2.4.
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Oxygen-cost diagram
The subjects were shown an Oxygen-cost diagram^^(Figure 2.1). The diagram 
consisted of a list of everyday activities positioned alongside a 100-mm vertical scale 
proportionally to their oxygen cost. The subjects were allowed sufficient amount of 
time to study the activity list. They were then instructed to mark the line at a point 
above which they would become breathless at their best. The result was expressed as 
the distance of the mark in millimetres above zero. Breathlessness was defined to the 
subjects as a feeling of an uncomfortable need to breathe rather than any other 
sensations, such as fatigue or vague chest discomfort.
Statistical methods
Comparisons of clinical characteristics between the AS and control groups 
were made, using Chi squared test with Yates' correction. The difference in the 
values from the Oxygen-cost diagram between the two groups was assessed, using 
Wilcoxon signed-rank matched-pairs test.
2.3.2 Results
Both groups were well-matched in terms of age and gender distributions 
(Table 2.4). Unintentionally, the two groups did not differ with respect to exercise 
and smoking habits. The values from the Oxygen-cost diagram in the AS group was 
significantly lower than that in the control group [ mean (SEM); 80.3 (3.4) mm in AS 
vs 89.4 (2.1) mm in controls, p = 0.042 ] (Figure 2.2).
2.3.3 Discussion
The significantly lower values from the Oxygen-cost diagram in the AS group
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indicate a greater magnitude of dyspnoea perceived during everyday activities among 
these patients. Thus, the result substantiates the finding from the initial survey as 
regards the presence of undue breathlessness among sufferers from AS.
9
Explanation must be given for the choice of VAS used in this study. Different 
forms of VAS for assessment of dyspnoea have been validated.94-96Although funda­
mentally similar to the others, an Oxygen-cost diagram has the particular strength 
that it comprises a list of everyday activities positioned alongside the scale. This 
ensures considerable precision of the scale in representing the breathing effort for 
various physical tasks perceived among different subjects.
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Summary of Findings
1 The prevalence of undue breathlessness (26 %) reported among patients with 
ankylosing spondylitis (AS) in the questionnaire survey is in contrast with the 
prevailing concept that respiratory symptoms in AS are rare.
2 The AS patients who took regular exercise or sports suffered from undue breath­
lessness less commonly than non-exercisers.
3 The symptom of undue breathlessness among the AS patients interviewed was not 
significantly influenced by smoking habit.
4 Relative to age-and gender-matched controls, the magnitude of dyspnoea, assessed 
by an oxygen-cost diagram, was greater among the AS patients, thus corroborating 
the main finding in the initial survey.
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b r i s k  walking uphill
medium walking uphill
slow walking uphill
b e d m a k in g
washing yourse lf  
s i t t i n g
br isk  w a lk in g  on the  ievei
heavy  sh o p p in g
m edium  walking
light sh o p p in g
slow walking  on th e  level 
s t a n d i n g
s leep ing
Figure 2.1 Oxygen-cost diagram. Vertical line is 100 mm long; and 
everyday activities listed are placed proportionately to their 
oxygen cost. Subjects were asked to indicate the point above 
which they thought they would become breathless.
(  From reference 94 )
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Values from OCD
p = 0.04
100 ooooo
Controls AS
Figure 2.2 Comparison o f  the values from Oxygen-cost diagram (OCD) 
between 20 patients with ankylosing spondylitis (AS) and 20 
matched controls. The AS group reported significantly lower 
values, indicating a greater magnitude o f  dyspnoea perceived. 
Bars represent group means.
Table 2.1
Frequency of symptoms and some information of 
interest in 62 patients with ankylosing spondylitis
Number %
Undue breathlessness 16 26
Chronic cough 10 16
Chr. sputum production 8 13
Tiredness 45 72
Worsened fitness 40 64
Exercisers 29 47
Smokers 38 61
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Tables 2.2
2x2 frequency tables comparing undue breathlessness 
betw een AS patients classed as a) exercisers/non-exercisers 
and b) smokers/non-smokers *
a ) Exercisers Non-exercisers Total
Undue breathlessness 4 12 16
(7 .4 ) (8 .5 )
No undue breathlessness 25 21 46
(2 1 .5 ) ( 24.4 )
Total 29 33 62
a )  df = 1, x2 = 4.107, p = 0.04
b ) Smokers Non-smokers Total
Undue breathlessness 12 4 16
( 9 .8 ) (6 .1 )
No undue breathlessness 26 20 46
(2 8 .1 ) ( 17.8)
Total 38 24 62
b )  df = l , x 2 = 1.708, p >  0.05 
* Values in parentheses are expected frequencies
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Tables 2.3
2x2 frequency tables comparing AS patients classed as 
smokers / non-smokers with respect to a) chronic cough 
and b) sputum production
a ) Smokers Non-smokers Total
Chronic cough 8 1 9
No chronic cough 30 23 53
Total 38 24 62
a ) Two-tailed p value = 0.12 ( Fisher's exact te s t)
b ) Smokers Non-smokers Total
Chr. sputum production 6 2 8
No chr. sputum production 32 22 54
Total 38 24 62
b ) Two-tailed p value = 0.64 ( Fisher's exact te s t)
Table 2.4
Clinical characteristics o f  20 AS and 20 control 
subjects in the Oxygen-cost diagram study
Controls AS subjects
Total number 20 20
A ge, yrs 46.4 (12.2) 46.5 (12.3)
Gender, male : female 13 : 7 13 : 7
Exercisers : Non-exercisers 9 :  11 13 : 7
Smokers : Non-smokers 7 : 13 9 : 11
Values are in mean (SD)
Chapter 3
43
Respiratory Muscle Performance among 
Patients with Ankylosing Spondylitis
3.1 Introduction
Rigidity of the chest wall, consequent to ankylosis of the costo-transverse 
and costo-vertebral joints, is a characteristic feature in ankylosing spondylitis (AS) 
and occurs early in the course of the d is e a s e d  Thus, reduced thoracic compliance 
has been consistently s h o w n . 4 7 , 5 1 , 5 2
The impaired mechanics of the thoracic cage in AS is likely to render the rib- 
cage muscles anatomically disadvantaged and their performance diminished. 
However, quantitative data on respiratory muscle strength (RMS) and endurance 
(RME) in patients with AS is scarce. Furthermore, the effects o f altered lung 
volumes and restricted chest expansion on RME and RMS in AS are unknown.
As described in chapter 1.7, the reference values for maximal respiratory pres­
sures (MRP) vary considerably among various sources in the literature ( Table 1.2 ). 
Further studies comprising matched controls would be of clinical value in delineating 
the efficiency of respiratory muscle performance in this condition.
Therefore, the aims of the present case-controlled study were as follows :
1. To comprehensively evaluate RMS and RME in AS patients
2. To assess the possible influence of diminished thoracic expansion and
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altered lung volume and subdivisions on RMS and RME in AS patients.
3.2 M ethods
Sample size determination
The required sample size in the present study was predefined based on the 
nomogram proposed by A lt m a n * *  1 (Table 1 . 4 ) .  This makes use of the standardised 
difference, which is the smallest clinically relevant difference divided by the esti­
mated standard deviation (SD) of the outcome variable concerned. The nomogram 
is appropriate for calculating power for a two-sample comparison of a continuous 
variable with the same number of subjects in each group.
One of the main outcome measures in this study was maximal inspiratory 
pressure (MIP). Previous studies have shown an SD of MIP among middle-aged 
population to be in the region of 22-31 cmH2 o(Table 1.2). The smallest clinically 
relevant difference of MIP values is a matter of clinical judgement. The coefficient 
of variation of MIP among various reports averages 25 per cent; therefore, it seems 
logical to assume that a difference in MIP of at least 25 cmH2 0  between two popula­
tions would be of clinical importance. Accordingly, the standardised difference for 
MIP is approximately 1.0.
From the nomogram, for a study to achieve statistical power o f 85 % at 5 % 
significance level with a standardised difference of 1.0, the total sample size of 
approximately 36 would be required.
Subjects
18 patients with definite AS were recruited in this study subsequent to the
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initial questionnaire survey. Exclusion criteria were similar to those in chapter 2.3.1.
18 individually age-and gender-matched healthy volunteers served as controls. The 
subjects were classed as smokers/non-smokers in a similar manner as in chapter 2.2.1 
Chest Expansion (CE)
CE was measured circumferentially around the chest wall at the level o f the 
fourth intercostal space with the subject standing with hands on head and arms flexed 
in a frontal plane.97 
Pulmonary Function Measurements
a) Lung volumes and Airway resistance
Lung volumes and airway resistance (Raw) were measured using a constant- 
volume body plethysmograph98,99(pK Morgan Ltd, Kent, UK). It consists o f a 
large chamber, a pneumotachograph, and three tranducers, which measure changes 
in box pressure (APbox), mouth pressure (APm), and flow at the mouth (V). The 
subject, seated in the closed chamber, breathes through a special mouthpiece- 
shutter assembly. At end-expiration, the shutter is closed to occlude the mouth­
piece, and the subject is asked to rhythmically compress and decompress his thorax 
by panting lightly against the closed shutter. While the shutter is closed, no airflow 
occurs within the airways, so APm equals the alveolar pressure changes (APalv).
During this manoeuvre, the APbox reflects the changes in thoracic volume, and is 
proportional to the APalv. The linearity of the inverse relationship of Pm and Pbox 
is preserved, because conditions in the respiratory system are isothermal. Thus, 
Boyle's law ( P iV j = P2V2 ), can be applied to these pressure-volume changes to 
calculate the volume being compressed, the subject's thoracic gas volume ( TGV ).
TGV was considered to represent functional residual capacity(FRC). Expiratory
reserve volume(ERV), relaxed vital capacity(VC) were determined from pneumota­
chograph. Residual volume (RV) was derived by subtracting ERV from FRC, i.e 
RV = FRC - ERV. Total lung capacity can be calculated by adding VC to RV, i.e 
TLC = VC + RV. All volumes were corrected to body temperature and pressure 
saturated with water vapour (B.T.P.S.).
For the measurement of airway resistance, the same shallow panting method 
is employed, in order to keep the subject's glottis open and prevent respiratory 
temperature artifacts in the box. While the subject pants through the open mouth­
piece, flow at the mouth and the corresponding cyclical changes in Pbox are 
recorded. The shutter is then closed briefly for TGV measurement. The ratio of 
APm/APbox (shutter closed) is divided by the ratio V/APbox (shutter open). The 
quotient represents the airway resistance,
b) Diffusing capacity of the lung for carbon monoxide (DLco)
DLco was measured by the single-breath technique as described by Ogilvie 
et a/100(Transfer test, PK Morgan Ltd, UK). The subject is connected to a spiro­
meter with a "balloon-in-box" system, inhales a maximum breath from RV (VC) of 
a gas containing 0.3 % Carbon monoxide, and Helium and air mixture, and is 
instructed to hold his breath for 10 seconds. During exhalation, an alveolar sample 
is collected in a small bag and analyzed for CO concentration. The CO uptake 
during the breath-holding time can be calculated from the inspired and expired CO 
concentrations.
All procedures were performed in accordance with the guidelines as
47
recommended by the British Thoracic Society and the Association of Respiratory 
Technicians and Physiologists.^* Standard reference values for lung v o l u m e s * ^  
and D L c o * 0 3 w e r e  use(i in the AS subjects, the calculation of per cent predicted 
values was based on the height prior to onset of the disease where this was reliably 
known.
Determination of Respiratory Muscle Strength (RMS)
Maximal respiratory pressures (MRP) were used as indices of global respira­
tory muscle strength. Maximal inspiratory pressure (MIP) and expiratory pressure 
(MEP) were measured using a digital mouth pressure meter (Precision Medical,
Yorks, UK)(Figure 3.1). This equipment samples the signal at 16 Hz and an integral 
microprocessor identifies the one second period containing the maximum average 
pressure during inspiratory and expiratory manoeuvres provided a minimum duration 
of 1.5 seconds is made for each effort. A 2 mm hole (leak) exists at the centre of 
inspiratory and expiratory valves, preventing the subject from generating additional 
pressure with facial muscles. It has been shown to provide reliable and accurate 
measure of MRP in normals and in patients with respiratory disorders.6* An oval 
flanged rubber mouthpiece(intemal diameter 26 mm, external diameter 34 mm) was 
firmly attached to the mouthpiece adaptor of the meter. Subjects were seated and 
noseclips applied. MIP was measured from FRC and MEP from TLC. A minimum 
of 5 efforts were made for each manoeuvre until the two highest readings matched 
within 10 % in an attempt to minimize learning effect.68 ^  interval of at least 1 
minute was adopted between each effort. MIP was measured before MEP and instruc­
tions and demonstrations of the correct manoeuvre were always given. Although MIP
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is in fact a negative value with respect to ambient pressure, it is reported here as a 
positive value for clarity of discussion.
Assessment of Respiratory Muscle Endurance (RME)
RME was assessed using an inspiratory resistive breathing protocol adapted 
from the techniques previously described70>71 (Figure 3.2). The subject with a nose- 
clip in place sat and breathed through a resistive training device (RTD)(PFLEX, 
Healthscan, USA) incorporating six adjustable alinear inspiratory orifices and a one­
way expiratory valve. Mouth pressure (Pm) was continuously displayed on an oscil­
loscope for a visual feedback via a differential pressure transducer (Gould Statham 
P50) connected with the mouthpiece of the RTD. A pressure range o f -130 to +130 
cmH20 was calibrated before each trial. The subject was instructed to inspire and 
expire according to the sound signal generated from an electrical metronome. 
Inspiratory duration (Ti) was set at 1.7 s and total breath duration (Ttot) at 2.6 s, thus 
giving rise to a duty cycle (Ti/Ttot) of 0.4 and a breathing frequency of 14/min. A 
square wave and a target line were drawn on the oscilloscope screen and the subject 
was encouraged to maintain the required breathing pattern and target pressure through­
out the run. Oxygen saturation (Sa02) was continuously monitored using a pulse 
oximeter (Biox 3740). For the purposes of this study, only orifice 4 of the RTD was 
used throughout since, in a preliminary study on 5 AS patients, orifice 4 was found to 
be the most suitable for producing sufficient airflow resistance yet allowing adequate 
ventilation. This is in contrast with a previous study on patients with chronic airflow 
limitation^! in which larger orifices (1,2 and 3) were found suitable. The explana­
tion clearly lies in the fact that the latter group of patients were inherently limited by
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airflow obstruction. As the orifice size was fixed, the mean flow rate required to 
achieve each target pressure was unique. Consequently, no attempts were made in this 
study to measure inspiratory flow rate as this was constrained via control of the other 
components of the breathing strategy.
In order to familiarize the subjects with the breathing apparatus and the audio­
visual feedback, a practice session was held the day prior to the actual testing in which 
the subject breathed through the RTD and the target Pm was set at approximately 20 % 
of the baseline MIP for 10 minutes. This target Pm and the required breathing pattern 
were easily accomplished by all subjects. In the actual test session, another practice 
run of 5 minutes was given. Thereafter, the target Pm was raised to 70 % of MIP. The 
subject was constantly encouraged to maintain the target pressure and the breathing 
pattern. Endurance time (Tlim) was defined as the moment at which the target Pm 
could not be maintained for three consecutive breaths or oxygen desaturation (a fall of 
SaC>2 > 4 % from the baseline value) developed.
Statistical methods
Values are presented as mean (SD) or mean (95 %  Cl) as appropriate. Com­
parisons of categorical variables between the AS and control groups were made by 
Chi squared test with Yates’ correction. Lung function data, MIP, MEP and Tlim 
between the two groups were compared using Wilcoxon signed-rank matched-pairs 
test. Relationships between lung subdivisions and MIP, MEP and Tlim in each group 
were assessed using product-moment correlation coefficients (r). Statistical signi­
ficance was assessed at 5 % level. In view of the multiple significance testings 
involved in the correlations between lung subdivisions and MIP, MEP and Tlim, the
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B o n f e r r o n i  c o r r e c t i o n ^  w a s  a p p l i e d .
3.3 Results
The two groups were well-matched with respect to age, gender, body mass index 
and smoking habit ( Table 3.1).
Pulmonary Function Results ( Table 3.2 )
The AS group had significantly smaller VC (p=0.001) and TLC (p=0.002) as 
compared with the control group, corresponding to mean percentage predicted values 
of 76 % and 85 % respectively. Although the mean FRC in the AS group was compa­
rable with that of control group, the FRC/TLC was significantly higher (p=0.041) 
because of the smaller TLC. FEVj was smaller in the AS group; however, the
FEV j/VC remained normal. Raw and DLco were also normal.
Maximal Respiratory Pressures ( Figures 3.3 and 3.4 )
In the AS group, mean MIP was 83 (95% Cl 69,97) cmF^O and mean MEP 
was 111 (95% Cl 96,126) cmL^O. Both indices did not differ from those of 
controls (p-0.45 and 0.80 respectively).
Respiratory Muscle Endurance ( Figure 3.5 )
In contrast with MRP, Tlim was significantly shorter in AS group with a mean 
of 128 (95% Cl 79,176) seconds as compared with control group, mean 258 (95% Cl 
205,310) seconds (p=0.009). In no occasion was the test terminated on account of 
C>2 desaturation.
Correlations between MRP, Tlim and Lung Subdivisions
In the control subjects, there were no significant correlations between lung
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subdivisions and MRP or Tlim ( Table 3.3 ).
In the AS subjects, MIP did not correlate with any lung subdivisions or CE 
(Table 3.4). MEP correlated with VC (r=0.67, p=0.042) and TLC (f =0.68, p=0.042).
In contrast, Tlim correlated inversely with FRC/TLC (r=-0.68, p=0.042) but not with 
other lung subdivisions or CE. Figure 3.6 shows the inverse correlation between 
Tlim and FRC/TLC in the AS group.
3.4 D iscussion
The present study provides no strong evidence that respiratory muscle strength, 
assessed by maximal respiratory pressures, in patients with ankylosing spondylitis is 
reduced. However, the efficiency of respiratory muscles in this condition becomes 
evidently impaired during sustained breathing at high inspiratory pressures. It would 
be of clinical value to furthur study whether the impaired respiratory muscle endurance 
plays an important role in exercise intolerance among these patients.
Sample size determination
A study with an overlarge sample may be deemed unethical through the unneces­
sary involvement of extra subjects and the correspondingly increased costs. On the 
other hand, a study with a sample that is too small will be unable to detect clinically 
important effects. One of the common features among clinical studies is the involve­
ment of multiple outcome measures which renders sample size determination difficult.
The same applies to the present study, of which there were three main outcome 
variables, namely MIP, MEP and Tlim. Nonetheless, this study has attempted to pre­
define the required sample size based on the currently available data on MIP in normals.
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Pulmonary Function Im pairm ent in AS
The findings of a slight reduction in TLC and, to a greater extent, VC in patients 
with AS are broadly in agreement with previous studies.44,47-49,51 The normal mean 
FRC and RV agrees with some reports44,50,51 but differs from others.45-48 These 
discrepancies may be due to differences in stage of the disease and, to a larger extent, 
differences in reference values used. The normal DLco is in line with previous 
reports 40,49
O f more clinical significance is the finding, in the AS group, of a higher ratio 
FRC/TLC which has previously received little attention. In contrast with interpreting 
the absolute FRC, using the ratio FRC/TLC takes into consideration the relatively 
smaller total lung size present in the majority of AS patients. The higher FRC/TLC in 
the AS subjects implies that their resting lung position is elevated. This finding lends 
further support to the notion that the level of fixation of the thorax in AS occurs closer 
to full inspiration than in normal persons.46-48
It is noteworthy that, whilst the FRC/ TLC ratio is increased in the AS group, 
RV is not similarly increased. Residual volume, the volume of gas in the lung at the 
end of a full expiratory effort, is determined by a balance of force, including the 
strength o f the accessory muscles of expiration, the inherent incompressibility of the 
thoracic cage, and the traction exerted on airways by fibrous stroma of the lungs. 103 
While resting lung position may be altered, a forced manoeuvre may involve use of 
reserve capacity, notably the accessory muscles of expiration which was found to be 
preserved in the present study. Thus, the FRC/ TLC ratio could be an early evidence 
of a process which will later show in an abnormality of residual volume.
53
Also worthy of note is the finding of a slight reduction in mean FEViin the AS 
subjects. FEV \ is dependent upon airway resistance and the force and speed of 
contraction of the thoracic and abdominal respiratory muscles. However, neither the 
airways resistance nor the indices of respiratory muscle strength was impaired in 
this group of AS patients. This reduction may therefore be explained by the relatively 
small lung volume since the ratio FEVj/VC remained normal in the AS group. 
Respiratory Muscle Strength (RMS)
Maximal respiratory pressures (MRP) measured at the mouth are simple, non- 
invasive indicators o f global RMS. 104 There was no evidence that global RMS in 
patients with AS was reduced in the present study.
Furthermore, this study has shown that MEP correlates with VC and TLC in AS 
patients. These findings corroborate the concept that the expiratory muscles are longer 
and nearer to their optimal resting length at high lung v o l u m e . 62 The normal lung 
volumes in the control group, however, did not allow the lung volumes to exert their 
influences on MEP.
Vanderschueren et a lP &in a study of 30 patients with AS, reported a significant 
reduction in MRP among these patients when compared to the reference values of 
A r o r a . 6 6  a  different conclusion may have been drawn if  these values had been related 
to reference values from other sources. As a matter of fact, the MIP at FRC in AS 
patients in the present study, mean 83 (SD 30.3) cmH20, was in close agreement with 
their study, mean 75.1 (SD 29.4) C111H2 O, as were the MEP at TLC from both studies, 
means 111 and 110.5 (SD 32.5 and 36.8) cmH20respectively.
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Respiratory Muscle Endurance
Endurance time (Tlim) determined by the method used is subject to several 
sources of error. The high target pressure undoubtedly requires a high level of 
motivation and the necessity to control the breathing strategy means that adequate 
familiarization needs to be attained prior to the actual testing. From the practical 
standpoint, it is sometimes difficult to ascertain the moment at which the target mouth 
pressure (Pm) is not maintained for three consecutive breaths. In the present study, 
all the subjects who participated were well motivated and sufficient practice runs were 
given to both groups. Furthermore, the endpoint criterion of Tlim was carefully and 
strictly applied in all trials.
In a study of 5 healthy volunteers on the relationship between Tlim and Pm, 
Roussos et found that Pm < 6 0 %  of MIP could be generated indefinitely 
(Pmcrjt). Consequently, the target Pm in the present study was set at 70 % of MIP. 
Bellemare & G r a s s i n o ^ 3  proposed tension-time index of the diaphragm (TTIdi).
TTIdi is the product of contractile force and duration, where force is expressed as the 
ratio of transdiaphragmatic pressure (Pdi) to maximum Pdi, and duration is expressed 
as duty cycle. Tlim could be related to TTIdi by the expression:Tlim = 0.1 (TTIdi)"3 6, 
which is valid when TTIdi is in excess of 0.15. Since MIP has been shown to correlate 
closely with Pdi, 106 tension-time index can be applied to the global inspiratory 
muscles based on the relationship of Pm / MIP instead of Pdi/Pdimax. The tension­
time index in the present study was 0.28 and Tlim would be predicted to be between 
7-10 mins. Although not in excellent agreement, the mean Tlim in the control group 
was 4.18 mins.
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The striking finding is the markedly shorter Tlim in the AS group with a mean 
of 2.08 mins. In a study on 25 patients with AS and matched controls, Josenhans 
et aP$  calculated a mean diaphragmatic contribution to a tidal volume of 84.8 % in 
AS subjects compared with 68.4 % in controls. Moreover, Grimby et a fl4 observed 
that the relative contribution of the rib cage to ventilation decreased further during 
hyperventilation. When taking the findings from the two studies and the present 
study together, it is evident that the diaphragm in patients with AS, although it can 
compensate sufficiently during tidal breathing, tires more quickly than in normal 
individuals during breathing at high inspiratory pressures indicating relative inefffi- 
ciency of the diaphragm in this condition.
While a correlation does not necessarily indicate a causal relationship, the 
inverse correlation between Tlim and FRC/TLC in the AS group suggests that an 
elevated resting lung position, as reflected by the higher FRC/TLC, plays a significant 
role in the shorter endurance time. This adds further evidence to the observation that 
at lung volumes above normal FRC, the diaphragm and other inspiratory muscles are 
foreshortened and their contractile force curtailed. 106 It is noteworthy that this 
effect, in the presence of normal FRC/TLC, was not evident in the control group.
Although RME testing evaluates the performance of the respiratory muscles, 
their work can by no means be assessed in vivo in isolation from other groups of 
skeletal muscles. Hence the relative lack of physical fitness consequent to the 
chronic nature of the disease may also contribute to the shorter Tlim in AS patients.
Respiratory muscle endurance can be interpreted in terms of the balance 
between energy stores, utilization and renewal.66 Thus nutritional status has been
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shown to influence diaphragmatic m a s s  107 and respiratory muscle strength. 108 
Impeded diaphragmatic blood flow during cardiogenic shock has also been shown to 
impair respiratory muscle force in experimental dogs 109 although this has not been 
fully established in the presence of normal arterial blood pressure and cardiac output 
in man. Data from the present study did not permit an analysis of the role of these 
factors since all the subjects were well.-nourished, as judged by body mass index, and 
no subject was in a compromised cardiocirculatory status.
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S um m ary  o f F indings
1 There was no evidence that respiratory muscle strength, assessed by maximal 
respiratory pressures, in the 18 AS subjects was reduced.
2 Relative to age-and gender-matched controls, respiratory muscle endurance in the 
AS group was significantly shorter. This finding indicates that, although the dia­
phragm compensates well in AS during tidal breathing, the respiratory muscle 
performance becomes evidently impaired during sustained breathing at high inspi­
ratory pressures.
3 The reduced respiratory muscle endurance in AS may in part be attributed to the 
elevated resting lung position, hence the inverse relationship between the 
endurance time and the ratio FRC/TLC.
57
M ou th p iece
M ou th p iece
A daptor
Upper a irw a y  
c o v e r
K nurled  r e t a i n i n g  
n u ts
Upper a irw a y
S l i d e  v a lv e
J Lower a irw a y
R e ta in in g  s c r e w s
Sam ple tu b e
Figure 3.1 Month pressure meter and its schematic illustration. 
(  The schematic illustration is by courtesy o f  
Precision Medical, N  Yorks, UK)
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Figure 3.2 Schematic illustration o f  the experimental set-up fo r  the
assessment o f  respiratory muscle endurance. The subject was 
encouraged to maintain a target mouth pressure o f  70 % MIP. 
Duty cycle (Ti/Ttot) and breathing frequency were kept constant 
by means o f  an electrical timing device.
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Figure 3.3 Comparison o f  maximal inspiratory pressure (MIP) between 
18 subjects with ankylosing spondylitis (AS) and 18 matched 
controls. Horizontal bars represent group means.
NS  = not statistically significant ( p >  0.05 )
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Figure 3.4 Comparison o f  maximal expiratory pressure (MEP) between 
18 subjects with ankylosing spondylitis (AS) and 18 matched 
controls. Horizontal bars represent group means.
NS  = not statistically significant ( p >  0.05 )
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Figure 3.5 Comparison o f  respiratory muscle endurance time (Tlim) 
between 18 subjects with ankylosing spondylitis (AS) and  
18 matched controls.
Horizontal bars represent group means.
Tlim (s)
r = -0.68 
p = 0.042
n =18
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Figure 3.6 Inverse relationship between endurance time (Tlim) and 
FRC /  TLC ratio in 18 subjects with ankylosing spondylitis
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Table 3.1
Clinical characteristics o f the AS and Control subjects 
in the respiratory muscle performance study *
Controls AS subjects
Total number 18 18
A ge, yrs 44 (11.1) 44 (11.1)
G ender, male : female 1 2 : 6 1 2 : 6
Smokers: Non-smokers 6 :  12 8 : 10
B M I, kg m-2 25.1 (2.7) 26.7 (4.5)
Chest expansion, cms not measured 2.0 (0.7)
Values are mean (SD).
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Table 3.2
Pulmonary function data in 18 AS and 18 controls
Controls AS subjects
F E V i , L 3.53 (0.80) 2.78 (0.70) +
% predicted 102 (12.9) 80 (13.0)+
V C , L 4.65 (1.04) 3.55 (0.88) +
%  predicted 107 (19.8) 76 (12.1) +
FEVi / VC , % 76 (6.5) 78 (7.2)
FRC, L 4.01 (0.92) 3.83 (1.08)
%  predicted 118 (20.4) 121 (40.4)
R V , L 1.69 (0.46) 1.78 (0.63)
%  predicted 101 (23.9) 111 (31.8)
TLC, L 6.34 (1.41) 5.33 (1.23) +
%  predicted 103 (15.5) 85 (12.7) +
FRC / TLC , % 63.7 (8.6) 71.6 (9.5) #
RV / TLC , % 26.6 (4.3) 33.2 (7.4) +
R aw , kPa-Fsec"1 L_1 0.15 (0.05) 0.15 (0.04)
Values are mean (SD) 
+ p < 0.005
# p < 0.05
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Table 3.3
Correlation coefficients betw een M IP, M EP, Tlim 
and lung volumes in 18 control subjects *
M IP M EP Tlim
VC 0.07 0.18 0.30
FRC 0.05 0.38 0.45
RV 0.07 0.42 0.35
TLC 0.08 0.28 0.34
FRC / TLC -0.03 0.21 0.20
RV / TLC -0.01 0.38 0.13
* None of these correlations reached statistical significance at 5% level.
Table 3.4
Correlation coefficients betw een M IP, M EP, Tlim and 
lung volumes, chest expansion in 18 AS subjects
M IP M EP Tlim
VC 0.50 0.67 + 0.08
FRC 0.33 0.37 -0.48
RV 0.36 0.39 -0.49
TLC 0.54 0.68 + -0.19
FRC / TLC -0.18 -0.38 -0.68 +
RV / TLC -0.04 -0.13 -0.58
Chest expansion 0.01 0.11 0.12
+ p = 0.042 (adjusted p value according to Bonferroni method).
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"A respiratory physiologist offering a unitary explanation 
fo r  breathlessness should arouse the same suspicion as 
a tattooed archbishop offering a free ticket to heaven "
The warning o f  Campbell and Howell 122
Chapter 4
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Exercise Limitation, Exertional Dyspnoea, and 
Cardiorespiratory Response to Exercise among 
Patients with Ankylosing Spondylitis
4.1 Introduction
As set out in the introductory chapter, the mechanism(s) underlying exercise 
intolerance in patients with ankylosing spondylitis (AS) remains unclear despite 
research spanning many decades. Although deconditioning or cardiac impairment 
is believed to play an important role, the supporting data have been scanty.40
The recent development of noninvasive cardiac imaging techniques has led to 
increased recognition of valvular^  as well as myocardial disease in A S .^  In a study 
of 30 AS patients with no history of cardiorespiratory disease, ^ e a rly  diastolic abnor­
malities of the left ventricle were documented by echocardiography in 16 patients; 
this finding was reconfirmed a year later in 15 of them. Whether the apparently high 
prevalence of cardiac diseases in AS has a major impact on exercise tolerance is little 
known, however.
Previous studies in chapter 2 have confirmed that AS patients perceive greater 
magnitude of breathing effort than normal individuals during everyday activities. It 
would be of clinical value to assess whether the higher intensity o f breathing effort
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among AS patients limits their exercise tolerance and also to explore the possible 
relation between exertional dyspnoea and diminished chest expansion and impaired 
lung volumes.
Therefore, the present study was aimed to :
1) Systematically evaluate the degree of perceived exertional dyspnoea 
and its possible relation with chest restriction and altered resting lung 
volumes in AS patients.
2) Comprehensively examine the cardiorespiratory response to exercise 
in AS patients.
3) Comprehensively examine the mechanism(s) responsible for exercise 
limitation in AS patients.
4.2 M ethods 
Subjects
The appropriate sample size for the present study could not be predefined with 
confidence in view of the involvement o f multiple outcome variables. Nonetheless, a 
total sample size of 40 was considered adequate for the purposes of the study. 20 AS 
patients and 20 age-and gender-matched healthy volunteers were recruited in a similar 
manner as in the previous study (chapter 3.2). Exclusion criteria were as described in 
chapter 2.3.1. Clinical characteristics of the two groups are summarised in Table 4.1. 
Chest Expansion and Pulmonary Function M easurements
Chest expansion (CE), static lung volumes, airway resistance (Raw) and diffus­
ing capacity of the lungs for carbon monoxide (DLco) were measured using the
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techniques and reference values as described in chapter 3.2.
In addition, maximum voluntary ventilation (15-s M W ) was measured, using a 
pneumotachograph. Each subject produced 3 efforts seperated by a minimum of 
3-minute rest. The highest value was chosen for the subsequent calculation of 
breathing reserve (BR), as following : BR = [ 1-Vgmax/MVV JxlOO %.
All pulmonary function tests were carried out within one week prior to exercise 
testing. Pulmonary function data are presented in Table 1.
Cardiopulmonary Exercise Testing (CPX)
a) Apparatus (Figure 4.1)
Subjects were familiarised with the apparatus prior to the actual testing. CPX 
was performed on an electrically braked cycle ergometer (Cardiokinetics Ltd, UK) 
with the subject breathing through a low dead space (35 ml), low resistance valve box. 
The valve box incorporated a turbine ventilometer in the inspired limb for measuring 
ventilation. Expired gas was collected in an 8-L mixing chamber and analysed for O2 
and CO2 contents by an infra-red spectrometer and a paramagnetic analyser, respec­
tively (PK Morgan Ltd, UK). The output of the ventilometer and gas analysers were 
processed by an online microcomputer (PK Morgan Exercise Test System) giving 
continuous recording of O2  uptake (VO2 ), CO2  production (VCO2 ), inspired minute 
ventilation (Vg) and breathing frequency (f). Electrocardiogram (ECG) was
monitored throughout the test.
b) Monitoring of blood gases during exercise
Transcutaneous O2 and CO2 tensions (tcPC>2 and tcPCC>2) were monitored 
using a combined O2 /CO2 transcutaneous electrode(TINA electrode, Radiometer Ltd,
Copenhagen) and its monitoring system (TCM3)(Figures 4.2 a and b). The electrode 
consists of a Clark polarographic electrode that measures O2  and modified Severing- 
haus glass pH electrode integrated into a single unit that can be applied directly to the 
skin. 11® The unit also incorporates a thermostatically controlled heater which 
promotes local hyperaemia, enabling O2  and CO2  levels in cutaneous capillaries to 
approach arterial levels. The electrode was sited on the volar aspect o f the forearm 
and allowed to settle, heating to 45°C. When stable reading was apparent (approxi­
mately 5 minutes), the baseline tcPC>2 and tcPCC>2 were recorded. In a recent s t u d y , 35 
a combined transcutaneous O2 and CO2  electrode has been shown to provide a reliable 
noninvasive estimate of gas exchange during exercise provided a maximal permissible 
temperature is attained (45°C), together with gradual stepups in workload at 2 minute 
intervals.
c) Protocol for exercise testing
The subjects were seated on the ergometer, and monitored at rest for two mins. 
to establish a steady state. They then began pedalling at a work rate of 25 watts(W) at 
a speed of 40-50 rpm. Thereafter the load was increased by 15-25 W every two mins. 
to symptom limitation (breathlessness, leg fatigue, chest pain). Work capacity
(Wcap) was defined as the highest work rate sustained for at least 30 seconds. Exer­
cise variables were measured and averaged over the last 30 seconds of each work load 
and at peak exercise. VO2 and VCO2  were corrected to standard temperature and 
pressure, dry (STPD). Exercise parameters were compared with reference values of 
of Jones. H I  Anaerobic threshold (AT) was derived by the V-slope m e t h o d . 3 8  Since 
the typical 90 %  response time is 30 seconds for the O2 electrode and 60 seconds for
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the CC>2 e l e c t r o d e ,  ^  ^  the tcP02 and tcPCC>2 readings were taken at the end of each 
work rate. These values allowed the calculation of alveolar-arterial O2 pressure 
difference [ P(A-a)C>2] physiological dead space-tidal volume ratio (VjyVx), 
using standard formulae 113 as follows :
P a 0 2 (mmHg) = FIO2  x (Pr-47) - PaC02/R , and 
P(A-a)02 = P a^ 2  - PaC>2
where P a 0 2  is the ideal alveolar O2 pressure; FIO2  Is fraction of inspired O2 , dry; 
PB is barometric pressure in mmHg; R is the gas exchange ratio;
PaC>2 and PaC02 refer to arterial O2 and CO2 pressures, determined transcutaneously 
as described above.
VD/VT = (PaC02-PEC02)/PaC02 - VDM/Vt
where PECO2 Is mixed expired PCO2 ; Vdm is mechanical dead space in litres;
Vt  is tidal volume in litres.
Evaluation of Breathlessness Leg Fatigue
The modified Borg category scale 114(Figure 4.3)was used to rate the intensity 
of breathlessness and leg fatigue perceived during exercise. Simple verbal expressions 
were linked to numbers from 0 to 10, zero being no appreciable breathlessness or leg 
fatigue and 10 being maximum. Full explanations were given prior to the test and the 
scale was hung in front of the subject printed on a large sheet of paper. During the 
CPX, the subject was instructed to estimate the breathing effort (breathlessness score, 
BS) at the end of each work load by pointing to the corresponding number on the chart. 
In order to avoid any bias on the part of the investigator, no further clarification was 
given unless requested. However, care was taken to instruct the subject only to rate
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the breathing effort and not other sensation during exercising. At peak exercise, the 
subject was asked to give BS as well as leg fatigue score (LS). BS values so obtained 
allowed the changes in magnitude of breathlessness in relation to work rate(ABS/AWR), 
ventilation (ABS/AVg), and oxygen uptake expressed as per cent predicted maximum 
[ABS/AV02(%pred.max)] to be examined.
Statistical Methods
Values are presented as mean (SD) or mean (SEM) as appropriate. Compari­
sons of categorical variables between the AS and control groups were made using 
Chi squared test with Yates' correction. Wilcoxon signed-rank matched-pairs test 
was used to evaluate the differences between the two groups with respect to baseline 
lung function, and various physiological variables. Relationships between ABS/AVg 
and chest expansion, lung volumes, breathing frequency (f), and tidal volume at peak 
exercise as a per cent of VC (Vjmax/VC) were assessed, using Pearson's correlation 
coefficients. The slopes of ABS/AWR, ABS/AVg, and ABS/AVC>2 (%pred.max) were 
expressed as means of slope from linear regression analysis o f each subject's data 
according to the " standard two stage " method. 1 ^  Statistical significance was 
assessed at 5 % level.
4.3 Results
Pulmonary Function Results (Table 4.1)
VC and TLC were significantly smaller in the AS group averaging 78 %  and 
86 % predicted values, respectively. The AS subjects achieved significantly lower
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M W  with a mean of 106 L-min"! but Raw and DLco were within normal ranges.
Work Capacity and Symptoms Associated with Exercise (Table 4.2)
The AS subjects achieved lower work capacity averaging 123 W compared 
with 148 W in controls (p=0.01)(Figure 4.4 a). Total exercise time was significantly 
shorter in the AS group (p=0.008)(Figure 4.4 b). V02max was significantly lower in 
the AS group with a mean of 25.2 ml*kg"l*min"l(75 %  predicted). The majority of 
the subjects in both groups ceased exercising on account of leg fatigue. Leg fatigue 
scores (LS) reported by the AS subjects were higher than those reported by the control 
subjects (p=0.003)(Figure 4.5 a). Mean breathlessness scores (BS) at peak exercise 
were comparable between the two groups(Figure 4.5 b). However, mean slopes of 
ABS/AWR, ABS/AVe, and ABS/AVC>2(% pred.max) were steeper in the AS group 
(p=0.03, 0.01 and 0.01, respectively), indicating higher intensity of breathing effort 
perceived among the AS subjects for equivalent levels of work rate, ventilation, and O2 
uptake achieved (Figures 4.6 and 4.7). No subjects experienced or ceased exercising 
due to chest pain.
Relation between Exertional Dyspnoea and Physiological Variables
As the slopes of ABS/AVe  were steeper than the slopes of ABS/AWR, the 
former were used to explore the possible relation between exertional dyspnoea and CE, 
resting lung volumes, f, and Vxmax/VC) in the AS subjects. However, there were no 
significant linear correlations between ABS/AVe  and any of these variables. Correla­
tion coefficients (r) between ABS/AVE and CE = 0.05, VC(%) = 0.08, RV (%) = 0.13, 
FRC (%) = 0.15, TLC (%) = 0.06, f  = 0.28 and VTmax/VC = 0.25 ( all p values > 0.05).
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Ventilatory Response to Exercise
Baseline respiratory variables were comparable between the two groups (Table 
4.3). Table 4.4 shows respiratory variables at peak exercise in the two groups. When 
compared with the controls, the mean AVe /AVCC>2 in the AS subjects was significant­
ly higher (p=0.01)(Figure 4.8 a). Importantly, both the AS group and the controls 
developed a fall in V jy V j and there was no major change in P(A-a)C>2 in either group. 
Also, their breathing reserve remained adequate(40 %). Peak-exercise Vg was higher 
in the control group but this did not reach statistical significance (p=0.55). At peak 
exercise, mean tidal volume in the AS group was significantly smaller (p=0.003) and 
was accompanied by a higher mean breathing frequency (p=0.03) when compared with 
the control group, indicating a tendency of the AS subjects to reach a high level of 
ventilation by increasing breathing frequency.
Cardiocirculatory Response to Exercise
At rest, mean heart rate was higher in the AS group than controls, albeit not 
statistically significant (p=0.12)( Table 4.3 ).
At peak exercise, the AS subjects achieved a mean heart rate o f 85 % predicted 
and their blood pressure response was normal. Heart rate response to aerobic uptake 
(AHR/AVO2 ) was significantly higher in the AS group (p=0.008) (Figure 4.8 b).
Although when compared with the control group the AT and O2  pulse at peak exercise 
in the AS subjects measured significantly lower (p=0.001)(Figure 4.9), their mean 
values were still within physiological ranges (AT = 44 % predicted VC^maxl 11 and 
O2  pulse = 95 % predicted normal *40)
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Oxygen pulse values at submaximal exercise in the AS group were constantly 
lower than those in the control group ( Figure 4.10).
4.4 Discussion
The present study has shown that effort tolerance in AS patients without cardio­
respiratory disease is considerably curtailed, the main limiting factor being musculo­
skeletal deconditioning. Although the ventilatory response to exercise in the AS group 
was raised, their breathing reserve remained adequate and gas exchange indices normal. 
The heart rate response to aerobic uptake was higher in the AS group; however, other 
cardiocirculatory variables were within physiological ranges. Thus, the elevated heart 
rate response appears to reflect a relative lack of physical fitness among the AS patients 
rather than an intrinsic cardiac pathology. Several points merit discussion. 
Pulmonary Gas Exchange in Ankylosing Spondylitis
Criticisms may be made on the calculation of gas exchange indices based on the 
tcPC>2 and tcCC>2 values in this study. The ease of use and reliability o f a combined 
C>2 and CO2  transcutaneous electrode have led to increasing clinical applications in the 
critical care setting, * ^  in exercise testing, 1 l^and in sleep studies. 1 By adopting 
a protocol with two minute workload increments and allowing the electrode to heat 
to 45°C, it has been shown to provide a valid estimate of gas exchange during exercise 
testing across the range of apparently normal persons to those with advanced cardio­
respiratory diseases.35 The accuracy of the transcutaneous electrode monitoring sys­
tem is further enhanced by initial in vivo calibration.35 However, in the present study 
it was apparent that the tcP02 and tcPCC>2 values in both groups of subjects were
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within the normal physiological ranges and direct arterial sampling would be difficult 
to justify in the control group; consequently, initial in vivo calibration o f the trans­
cutaneous electrode was deemed unnecessary.
The findings of a physiological fall in V d /V j, together with a lack of 
pathological widening in P(A-a)C>2, in the present study indicate that there is not a 
major gas exchange problem among the AS subjects. This finding agrees with the 
finding of Miller & S p r o u l e ^ w h o  observed normal P(A-a)C>2 V d /V t *n 12 AS 
patients. However, the finding differs from that o f Renzetti et al 39who reported 
increased V d /V t and significant arterial oxyhaemoglobin desaturation at rest and on 
exercise in most of the 12 AS subjects. The discrepancy may result from the 
differences in the methods used, and in the study populations. The subjects in the 
present study had no evidence of pulmonary parenchymal disease, as judged by 
recent chest radiograph.
Caution must be exercised when interpreting the finding o f a higher 
V£max/VC02 in the AS group, as compared with the controls. Vg/VCC^ is a good 
overall determinant of the efficiency of the lung as a gas exchange unit. Normally 
at maximal exercise the value ranges from 25 to 35.3 1» 141 Patients with gas 
exchange abnormality typically produce a V£max/VC02 of greater than 40.141 
Although comparatively higher in the AS group, their V£max/VC02 values still 
fall within normal range. This exemplifies the fact that statistical significance 
does not equate clinical relevance.
Factors Limiting Exercise Tolerance in Ankylosing Spondylitis
The majority of the AS subjects achieved a maximum heart rate of 85 %  pre-
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dieted and a respiratory exchange ratio of 1.10, suggesting that they performed up to 
their physiological limits. Furthermore, in this study M W  was measured rather than 
derived from a predictive equation, thus yielding accurate information on the breathing 
reserve of the individual subject.
Martinez et a fi  ^ recently  highlighted the limitation of a cardiopulmonary exer­
cise test in seperating cardiac limitation due to disease from deconditioning. Further, 
in the deconditioned patients, it is a cardiac limitation to exercise performance which 
determines endpoint. Nonetheless, in the current study, the anaerobic threshold and 
oxygen pulse among the AS patients by falling within the lower end of normal ranges 
indicate that the exercise intolerance was not due to cardiac disease.
The mean resting heart rate was higher in the AS group than controls, although 
not reaching statistical significance. This could be evidence of deconditioning.
More importantly, the configuration of oxygen pulse at submaximal exercise among 
the AS patients ( Figure 4.10 ) strongly indicates an element o f deconditioning rather 
than cardiac disease, as the latter would have produced a flat response.
The raised heart rate response to aerobic uptake should reflect the relative lack 
of physical fitness in this group of subjects. This is further supported by the higher 
degree of leg effort perceived at peak exercise among the AS subjects despite achieving 
lower work capacity. On the basis of these findings together with the normal breathing 
reserve and gas exchange, it is evident that deconditioning was the major factor limiting 
exercise tolerance in the AS subjects.
It is noteworthy that the anaerobic threshold, determined noninvasively, in the 
AS subjects measured significantly lower than in the control group although the abso-
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values still averaged > 40 % predicted VC>2max. Nonetheless, this finding indicates 
that the aerobic metabolism among the AS subjects was supplemented by anaerobic 
processes earlier than in the controls, implying a lack of aerobic fitness. Moreover, 
the resultant lactic acid accumulation is likely to contribute to the greater degree of 
leg fatigue perceived among these patients.
Exertional Dyspnoea in Patients with Ankylosing Spondylitis
While a visual analogue scale (VAS) was used in the assessment of dyspnoea 
in chapter 2.3, the Borg scale for ratings of perceived exertion was employed in the 
present study. The rationale behind this is based largely on the findings by Wilson 
et that, during exercise testing, the Borg scale is more reproducible, and also 
correlated with the level of ventilation more closely than the VAS. The greater 
degree of dyspnoea on exertion in th AS group, as reflected by steeper slopes of 
ABS/AWR, ABS/AVe, ABS/AVO2 , corroborated the previous findings in chapter 2. 
Since the majority of the AS subjects ceased exercising owing to muscular decondi­
tioning and did not reach a similar level of work rate or ventilation of the control 
subjects, peak-exercise breathlessness scores were comparable between both groups.
The extent of shortening of the inspiratory muscles as indirectly indicated by 
the tidal volume at peak exercise as a per cent of vital capacity, and the frequency of 
contraction, as indicated by breathing frequency, have been found to contribute inde­
pendently to the sensation of exertional dyspnoea in patients with a variety of cardio­
respiratory diseases.85,121 Data from the present study, however, did not reveal any 
strong association between the magnitude of exertional dyspnoea and CE, Vymax/VC, 
f, and resting lung volumes among the AS patients.
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The present study suffers from some limitations. The use of expired gas mixing 
chamber did not allow assessment of the possible influence of duty cycle (inspiratory 
duration as a proportion of total breath time) on the sensation of exertional d y s p n o e a . 2 8  
Furthermore, the lack of simultaneous measurements of mouth pressure and peak in­
spiratory flow during exercise precluded a direct assessment o f the relation between 
respiratory muscle tension and ratings o f exertional dyspnoea. 121
Nevertheless, the findings from the present study suggest that the severity of 
chest restriction, the impairment in resting lung volumes, and the magnitude of exer­
tional dyspnoea are seperate quantities which independently characterise the condition 
of patients with ankylosing spondylitis and that the warning of Campbell & H o w e ll  122 
should still be heeded.
Summary of Findings
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1 Aerobic power and work capacity are commonly reduced in patients with ankylosing 
spondylitis (AS), the major limiting factor being musculoskeletal deconditioning.
2 Despite an elevated ventilatory response to exercise when compared with controls, 
breathing reserve remains adequate and pulmonary gas exchange normal in patients 
with AS.
3 Relative to age-and gender-matched controls, heart rate response to aerobic uptake 
in AS patients is raised; however, other cardiocirculatory variables are appropriate 
to exercise level. Thus, the raised heart rate response to exercise reflects a lack 
of physical fitness among AS patients.
4 Relative to age-and gender-matched controls, patients with AS perceive a greater 
degree of leg fatigue on exertion, implying an element of muscular deconditioning.
5 During exercise, aerobic energy production in AS patients is supplemented by 
anaerobic processes earlier than in matched healthy individuals, indicating a relative 
lack of aerobic fitness. The resultant lactic acid accumulation may in part account 
for the greater degree of leg fatigue perceived among AS patients.
6 Relative to age-and gender-matched controls, patients with AS perceive a greater 
magnitude of exertional dyspnoea, corroborating the findings in the previous studies. 
However, dyspnoea is not the major symptom limiting exercise tolerance in AS.
7 The heightened perception of exertional dyspnoea, the impaired resting lung volumes, 
and the severity of chest restriction in AS are unrelated and represent seperate 
quantities which characterise the condition of patients with AS.
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Figure 4.1 Cardiopulmonary exercise testing. The subject cycles on a stationary, 
electrically-braked ergometer. An on-line ventilation and expired gas 
analyzer is seen on the left-hand side. Electrocardiogram and trans­
cutaneous PO2  and PCO2  are continuously monitored. Blood pressure 
is manually measured at baseline and peak exercise.
(  With kind permission from the subject)
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Figure 4.2 a )  A combined O2  and CO2  transcutaneous electrode, sited on the 
volar aspect o f  the forearm, 
b ) Transcutaneous PO2  and PCO2  calibration and monitoring units.
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Figure 4.3 Modified Borg scale fo r  Rating o f  Perceived Exertion. 
( From reference 114)
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Figure 4.6 Comparison o f  ABS/AVp between the AS and control subjects.
Each square represents a mean o f  data from  20 subjects unless 
specified otherwise. Bars represent SEM.
The mean slope o f  ABS/AVp was significantly steeper in the 
AS group ( p=0.01)
87
Breathlessness score
n=49
AS
Controls
8
7
6
5
n=20
4
3
n=17
2
0
20 30 40 50 60 70 80 90 100 110 
VOp (%pred.max)
Figure 4.7 Comparison o f ABS/A VO2 max( expressed as % pred.max) 
betM’een the AS and control subjects.
Each square represents a mean o f  data from  20 subjects unless 
specified otherwise. Bars represent SEM.
The mean slope o f  ABS/AV02max was significantly steeper in 
the AS group ( p=0.01)
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Figure 4.10 Comparison o f oxygen pulse at submaximal exercise 
between the AS and control subjects.
Each square represents a mean o f  data from 20 subjects unless 
specified otherwise. Bars represent SEM.
Few subjects in each group attained VO2 greater than 2.0 U  min; 
accordingly, data points at VO2 o f  2.5 and 5.0 are not shown.
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Table 4.1
Clinical characteristics and Pulmonary function data of 
20 AS and 20 matched controls in the exercise study
Controls 
(n = 20)
AS subjects 
(n=20)
A ge, yrs 46.4 (12.2) 46.5 (12.3)
Gender, male : female 13 : 7 13 : 7
Exercisers : Non-exercisers 9 :  11 13 : 7
Smokers : Non-smokers 7 : 13 9 : 11
Body mass index, kgm"2 25.3 (2.7) 26.1 (4.6)
V C , % predicted 106 (18.9) 78 (12.0) #
FR C , %  predicted 115 (21.7) 122 (38.6)
R V , %  predicted 103 (25.1) 110 (30.1)
T L C , %  predicted 104 (15.3) 86 (15.3) +
R aw , kPa^ sec'kL-1 0.15 (0.05) 0.15 (0.04)
D Lco, %  predicted not measured 98.0 (23.7)
M W , L-min'l 133 (6.6) 106 (7.4) +
Values are mean (SD)
+ p = 0.001 
# p <0.001
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Table 4.2
Metabolic variables and Symptom scores at peak exercise *
Controls
(n=20)
AS subjects 
(n=20)
VC^max, L min"! 2.31 (0.12) 1.82 (0.13)#
V0 2 max, ml-kg"l-min“l 33.1 (1.6) 25.2 (1 .4)#
, % predicted 93 (3.7) 75 (3.9)#
Work capacity, watts 148 (8.2) 123 (7.1)++
VC02max, Lm in‘ l 2.54 (0.12) 2.00 (0.15)#
R 1.10 (0.01) 1.10 (0.02)
BS 6.7 (0.5) 6.5 (0.6)
LS 7.1 (0.5) 8.7 (0.3)#
ABS/AWR 0.043 (0.003) 0.054 (0.005) +
a b s /a v e 0.115 (0.012) 0.147 (0.012)++
ABS/AV02(% pred.max) 0.045 (0.003) 0.084 (0.009)#
Values are mean (SEM) 
+ p = 0.03
+ + p = 0.01 
# p<0. 01
Table 4.3
Cardiorespiratory variables at baseline *
Controls 
n = 20
AS subjects 
n = 20
HR, bts min'1 73 (1.8) 78 (2.6)
BP systolic, mmHg 109 (3.0) 116(2.8)
BP diastolic, mmHg 67 (2.1) 69 (1.8)
f , breaths m in 'l 14 (0.5) 16 (0.3)
v t , l 0.41 (0.02) 0.45 (0.02)
v e , l 5.74 (0.10) 7.2 (0.25)
tc P 0 2 , mmHg 89 (1.0) 88 (2.1)
tcPCC>2 , mmHg 37 (0.9) 36 (0.7)
vD/vT 0.33 (0.02) 0.35 (0.01)
P(A-a)02,mmHg 12 (1.7) 15 (1.8)
* Values are mean (SEM)
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Table 4.4
Respiratory variables at peak exercise
Controls
(n=20)
AS subjects 
(n=20)
f , breaths min“l 30 (1.1) 35 (2.0) +
v t , l 2.28 (0.11) 1.81 (0.13) #
Vymax/VC 0.50 (0.01) 0.51 (0.02)
VE ,L 68.1 (3.3) 63.2 (3.6)
a v e /a v c o 2,l /l 23.7 (0.9) 26.8 (1.1) ++
B R , % 49 (2.2) 40 (2.0)
tcP 02 , mmHg 94 (1.5) 91 (2.5)
tcPC02 , mmHg 41 (1.3) 39 (1.1)
VD/VT 0.19 (0.02) 0.22 (0.03)
P(A-a)02,mmHg 14 (1.4) 17 (2.4)
* Values are mean (SEM) 
+ p = 0.03
+ + p = 0.01
# p = 0.003
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Table 4.5
Cardiocirculatory variables at peak exercise
Controls
(n=20)
AS subjects 
(n=20)
HRmax, b tsm in 'l 161 (3.2) 153 (3.7)
, % predicted 92 (4.6) . 85 (1.7)
BP systolic, mmHg 160 (3.0) 166 (6.8)
BP diastolic, mmHg 81 (2.0) 83 (2.4)
AHR/AV02, bts-L-1 39.5 (3.0) 50.0 (3.5)++
Oxygen pulse, ml b t 'l 14.6 (0.7) 12.0 (0.8) #
, % predicted 120 (6.5) 95 (4.5) #
AT, L-min’ l 1.35 (0.05) 1.10 (0.06) #
, %  pred V 0 2max 52 (1.9) 44 (2.1) +
Values are mean (SEM)
+ p = 0.01 
++ 0.00l< p  <0.01
# p = 0.001
Chapter 5
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Factors Influencing Aerobic Power among AS Patients
5.1 Introduction
The directly measured maximum oxygen uptake (VC^max) is a highly reprodu­
cible measure of the individual’s aerobic fitness. The V02max measures the capacity 
o f the working muscles to utilise oxygen and thus reflects the integrated function of 
the oxygen transport system including the lungs and chest bellows, heart, blood and 
active muscles.
The exercise study in chapter 4 has confirmed that aerobic power in patients 
with ankylosing spondylitis (AS) is commonly curtailed. Although the ventilatory 
and heart rate responses to exercise were elevated among the AS patients, the main 
limiting factor appeared to be musculoskeletal deconditioning as reflected by a greater 
magnitude of leg fatigue perceived at peak exercise despite achieving a lower work 
capacity as compared with matched controls. Furthermore, the study in chapter 3 has 
revealed the presence of diminished respiratory muscle endurance among AS patients 
although the maximum respiratory muscle strength is relatively well-preserved.
Thus, exercise intolerance in AS patients may result from muscular as well as 
pulmonary impairment. However the relative contribution of these factors to reduction 
in aerobic power among AS patients has not been quantitively examined. Improved 
knowledge in this area would be of clinical importance both in understanding the patho­
physiological basis of exercise limitation and in devising effective training/rehabili-
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-tation strategies for sufferers from this condition.
The objectives of the present study were therefore to identify and determine 
the individual and additive influence of lung vital capacity, respiratory muscle strength 
and endurance, peripheral muscle strength, limited chest expansion, and reduced spinal 
mobility on aerobic power among AS patients.
5.2 Methods
5.2.1 Sample size determination & Subjects
Multiple regression analysis was used to assess the additive influence of various 
variables on V02max and the appropriate sample size was decided in advance. As a 
general rule, the number of explanatory variables in the regression model should not 
exceed the square root of the sample size. *23 Five variables were defined as explana­
tory variables o f primary importance in the design stage of the study (see below). 
Accordingly, a total sample size of 25 was considered necessary.
25 patients with definite AS were recruited as described in the previous studies. 
Exclusion criteria were as described in chapter 2.3.1. The majority of the subjects 
were those who participated in the exercise study (chapter 4). The subjects were 
classed as exercisers/non-exercisers as described in chapter 2.2.1. Subject charac­
teristics are presented in Table 5.1.
5.2.2 Outcome variable
The outcome (response) variable in this study was maximum aerobic power
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(V02max), corrected for body weight, and expressed in ml kg‘ l -min‘ 1. It should be 
emphasised that capacity denotes total energy available whereas power means energy 
output per unit of time.
5.2.3 Potential explanatory variables
Based on the findings in the previous studies, a number of physiological varia­
bles appeared to potentially influence VC^max among AS patients. Five variables were 
considered to be of primary importance, namely, vital capacity, maximal inspiratory 
pressure, respiratory muscle endurance, chest expansion, and maximum strength of 
the quadriceps.
In addition, it would be of interest to explore the relations between VC>2 max 
and clinical indices of the extent/activity of the disease, namely, wall-tragus distance, 
the range of thoraco-lumbar movement, and erythrocyte sedimentation rate (ESR).
The effects of age, height, and lean body mass would also be examined. Furthermore, 
the influence of regular exercise on V0 2 max would be evaluated.
5.2.4 Measurements
V0 2 max was determined, using symptom-limited incremental cycle ergometry 
as described in chapter 4.2.
Vital capacity (VC), maximal static inspiratory pressure (MIP), respiratory 
muscle endurance time (Tlim), and chest expansion (CE) were measured as described 
in chapter 3.2.
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The total range of thoraco-lumbar (TL) movement in the sagittal plane was mea­
sured, using a spondylometer and expressed as degrees(°) as described previously. 124 
Wall-tragus distance was used as an index of thoracic kyphosis and expressed in cms.
5.2.5 Assessment of peripheral muscle function
Peripheral muscle function was assessed by measuring both muscle strength 
(knee extensors and hand grip) and amount (lean body mass).
Knee extensor strength
The force of a maximal voluntary contraction of the knee extensors was mea­
sured by the method described by Edwards et tf/125(Figure 5.1). The subjects sat 
upright in an adjustable, straight-backed chair with the lower leg dependent and the knee 
flexed to 90°. Adjustable straps were positioned around their waist and over both thighs, 
to prevent excessive movement during the manoeuvre. A cuff was placed around the 
leg just proximal to the malleoli and attached horizontally to an electrical strain gauge 
(Cranlea & Co., Birmingham, UK) with a digital read out. The subjects performed 3 
maximal voluntary contractions at approximately one minute intervals. The greatest 
peak force achieved was recorded. Peak torque was calculated from the product o f 
force and the distance between mid knee joint and mid point o f the lower leg strap, 
expressed in Newton-metre (N-m). A coefficient of variation of 4 % and a mean 
difference in strength of 6 % between the right and left leg have been noted. 126 Since 
the quadriceps femoris is the principal muscle engaged in knee extension, 127 the 
maximum force is abbreviated Qds for clarity of discussion.
Hand grip strength
Right hand grip strength was measured, using a hand-held dynamometer (Takei 
Company, Japan) with a digital read out. Measurement was made with the subjects 
standing, legs slightly apart, and arms extended downward. Peak grip strength was 
recorded from the maximum of three efforts separated by one-minute intervals and 
expressed in kgW.
Lean body mass (LBM)
LBM was calculated from the sum of skinfold thicknesses at four sites, namely, 
biceps, triceps, subscapular, and supra-iliac regions as described by Dumin et a l^S and  
expressed in kilograms. This method has been validated against "underwater weighing" 
technique and a high correlation coefficient (0.9) and a low intra-observer error( 3.5%) 
have been found. 128
5.2.6 Statistical methods
Descriptive data are presented as means, SD, and range. Single linear regression 
was used to assess the relationships between VC^max and various variables. The 
additive influence of explanatory variables on VC^max was examined, using forward 
stepwise regression analysis. Comparison of V02max between exercisers/non­
exercisers was performed directly and after adjusting for age. Level of probability 
was calculated from F or partial F values, and statistical significance was assessed at 
5 % level. The proportion of variance accounted for by each relationship is reported 
as (%), and adjusted for the expected chance prediction when the null hypothesis 
is true (adj.R2). 123
100
5.3 Results
The 25 AS subjects exhibited a wide range of functional impairment and degree 
of spinal mobility as shown by the data in Table 5.1. The mean VC>2max was 26.06 
ml-kg“l-min"l(75 %  predicted). 15 subjects were classed as exercisers and 10 as 
non-exercisers.
5.3.1 Factors influencing aerobic power in AS
The individual influences of the main explanatory variables on VC>2 max (ml kg’ l 
•min'l) were as follows :
VC
(L)
M IP
(cmH?0)
Tlim
( s )
CE
(cm)
Qds
(N-m)
adj.R2 (%) 12 11.8 0 0 46.9
F 4.29 4.21 0.49 0.25 22.16
P-value 0.05 0.05 0.49 0.62 <0.001
The influences of the other explanatory variables on V0 2 max were as follows :
Hand grip
(KgW)
LBM
(kgs)
Age Height W all-tragus
distance
TL
mobility
ESR
adj.R2 (%) 23.5 0 10.7 0 0 0 0
F 8.35 0.17 3.87 0.57 0.67 0.07 0.05
P-value 0.008 0.68 0.06 0.45 0.42 0.79 0.82
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Relationship of aerobic power to pulmonary function in AS
There was a weak relationship between VC (L) and V02max which accounted 
for 12%  of the total variance (p=0.05). The association was stronger after control­
ling for age, as described by the following expression :
1) V02max (ml-kg“l-min"l) = 16.4 - 0.17 age (yr) + 2.33 VC (L)
[ adj.R2 19.6 %, F 3.92, p 0.03, n 25 ]
It can be seen that the aerobic power decreased with advancing age. The addition 
of LBM, Ht, CE, Wall-tragus distance, TL mobility or ESR did not improve the total 
variance explained.
VC>2max was also weakly related to MIP (adj.R2 11.8 %, p 0.05). The relation­
ship was stronger after adjusting for the difference in age, as expressed by the following 
equation :
2) VC>2max (m lkg“hm in"l) = 28.1 - 0.16 age (yr) + 0.07 MIP (cmF^O)
[ adj.R2 17.9 %, F 3.63, p 0.04, n 25 ]
The addition of VC, LBM, Ht, CE, Wall-tragus distance, TL mobility or ESR 
did not improve the prediction of V02max based on MIP.
Tlim was not significantly related to aerobic power either directly or after 
allowing for the differences in age, VC, LBM, Ht, CE, Wall-tragus distance, TL mobi­
lity or ESR (p > 0.05).
Relationship of aerobic power to chest expansion in AS
There was no direct association between aerobic power and CE. However, the 
two variables became related at 10 % level once accounting for the difference in age, 
as expressed by the following m odel:
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3) V02max (ml-kg“l-min"l) = 42.0 - 0.24 age (yr) + 1.45 CE (cm)
[ adj.R2 12.3 %, F 2.68, p 0.09, n 25 ]
The addition of VC, MIP, LBM, Ht, Wall-tragus distance, TL mobility or ESR 
did not improve the total variance explained.
Relationship between aerobic power and peripheral muscle strength in AS
Qds and Hand grip strength were closely related to VC^max, accounting for 
46.9 % and 23.5 % of the total variance (p < 0.001 and p 0.008, respectively). The 
relation between Qds and V02max can be described as follows :
4) V02max (m lkg’ l-min’ l) = 14.7 + 0.10 Qds (N-m)
[ adj.R2 46.9 %, F 22.16, p < 0.001, n 25 ]
The above relationship is also shown in Figure 5.2. Since Qds was the single 
variable which exhibited the strongest association with VC^max, other variables were 
added to the regression model 4) in a stepwise fashion in order to try and explain the 
largest amount of the remaining variability in VC>2max.
LBM was the best second variable; the addition of LBM into the model further 
improved to total variance explained to 73 %, as expressed by the following equation :
5) V02max (ml-kg"l-min“l) -  27.8 + 0.17 Qds (N-m) - 0.39 LBM (kg)
[ adj.R2 73 %, Residuals SD 3.42, F 33.48, p < 0.001, n 25 ]
The multiple regression data for the above model is presented in Table 5.2.
The total variance explained improved only marginally after controlling for age, as 
described by the following expression :
6) V02max(ml-kg"l-min_l) = 31.7+0.16Qds (N-m)-0.37LBM (kg)-0.08age (yr)
[ adj.R2 74.5 %, Residuals SD 3.33, F 24.4, p < 0.001, n 25 ]
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It can be seen that LBM was inversely related to V02max since the latter was 
expressed in ml-kg" 1 min." 1 When expressed in L-min"l, VC^max was positively 
related to Qds and LBM as following :
7) V02max ( L-min'l ) = 0.378 + 0.011 Qds (N-m) + 0.005 LBM (kg)
[ adj.R^ 78.3 %, Residuals SD 0.29, F 44.2, p < 0.001, n 25 ]
The prediction of V02max based on Qds and LBM did not improve further with 
the addition of VC, MIP, CE, Ht, Wall-tragus distance, TL mobility or ESR ( adj.R^ = 
71.9, 72.1, 72.1, 71.9, 72.2, 72.1, 70.0 % respectively ).
Effect of regular exercise on aerobic power in AS
The exercisers(n=15) and non-exercisers(n=10) did not differ with respect to 
aerobic power when the VC^max values were compared directly ( p = 0.48, Mann- 
Whitney U test). However, the effect of regular exercise became apparent after 
accounting for the difference in age, as described by the following expression :
8) VC>2 niax (ml-kg"l*min"l) = 35.9 - 0.26 age (yr) + 4.36 Exercise , 
where exercise is a binary variable (Non-exerciser = 0, Exerciser =1).
[ adj.R^ 17.2 %, F 3.49, p 0.04, n 25 ]
Hence, after adjusting for age, the mean V02max was 4.36 m l'kg'l-m in’ l 
higher in the group classed as exercisers (p = 0.04).
5.3.2 Validity of the regression model
Multiple linear regression, like other statistical procedures, makes certain 
strong assumptions including :
i ) Independence in the observations.
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i i ) Random scatter o f the points about the best-fitting line.
i i i ) Constant variability about the best-fitting line for the values of the expla­
natory variables.
In the present study, each observation was made independently. The following 
plots can be used to verify the assumptions i i ) and i i i ) :
a ) Normal plot of the residuals. Residuals are the differences between the ob­
served values and the fitted values. A Normal plot of the residuals can be used to 
check the overall fit and verify that the residuals have an approximately Normal distri­
bution. As shown in Figure 5.3, the Normal plot of the residuals from the regression 
model 5) is very straight, and provides no reason to question the validity of the analysis, 
b ) Residuals plot against the fitted values. No pattern should be discemable in 
this plot. As shown in Figure 5.4, the variability of the residuals from the regression 
model 5) appears reasonably constant across the range of the fitted values.
In addition, the observed values and the fitted values derived from the regression 
were highly correlated (r = 0.86, p < 0.001), as shown in Figure 5.5.
5.4 Discussion
The results from the current studies must be interpreted in the context o f the 
severity o f patients studied. These AS subjects clearly exhibited at least moderately 
advanced disease, as evident by a mean chest expansion of 2.0 cm, a mean wall-tragus 
distance of 16.9 cm, and a mean spondylometric measurement o f 51°. The clinical 
implications therefore apply to those with a moderately advanced stage of disease.
The present study revealed that aerobic power in AS patients, without cardiac
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or pulmonary parenchymal disease, was closely related to peripheral muscle function. 
Pulmonary impairment and the severity o f chest restriction appeared to influence aero­
bic power only weakly. These findings therefore elaborate the findings from the pre-
i
vious studies (chapters 3 and 4).
As expected, advancing age exerts a significant influence on several physiolo­
gical variables including vital capacity ( eq. 1 ) and respiratory muscle strength ( eq .2 ). 
Furthermore, the effects of chest restriction, and regular exercise became evident only 
after controlling for the differences in age ( equations 3 and 8, respectively ).
As anticipated during the design stage of the study, significant relationships 
were found between aerobic power and most of the explanatory variables o f primary 
importance with the exception of Tlim. As described in chapter 3.2, respiratory mus­
cle endurance (RME) was assessed at 70 %  of MIP and the duty cycle (Ti/Ttot) was 
kept constant at 0.4. The lack of association between V02max and RME may result 
from the different duty cycles adopted by the subjects during various stages of the 
incremental exercise test. Alternatively, this may reflect muscle specificity with the 
two manoeuvres. The respiratory muscles are mainly involved during RME testing 
whereas several groups of skeletal muscles are engaged during cycle ergometry. 127 
The body consists o f two chemically distinct compartments, fat and fat-free(or 
lean body); the former is metabolically fairly inert. 129 Lean body mass (LBM) can 
be used as an index of muscle mass. During exercise, the demand on the oxygen 
transport system varies with the size of the active muscles. Hence, LBM everts a 
significant influence on VC^max, as evident in the equations 5, 6 and 7.
The present study emphasises the importance of assessing peripheral muscle
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function when evaluating exercise intolerance. Peripheral muscle impairment has 
also been implicated as a contributor to disability in patients with idiopathic thoracic 
scoliosis l^ a n d  cystic fibrosis. 131 Similarly, LBM has been shown to complement 
measures of pulmonary function in the prediction of disability in patients with chronic 
obstructive pulmonary disease. 132
It is noteworthy that chest expansion and vital capacity were related to aerobic 
power with a relatively similar degree. The findings suggests that chest restriction in 
AS expresses its influence on V02max through a reduction in vital capacity. The 
weakness of the influence of chest restriction, even after accounting for age, may be 
explained by the well-recognised diaphragmatic compensation for the work of breath-
ing. 74-75
A number o f methodological issues are worthy of discussion. Both the force 
of maximum voluntary contraction of the quadriceps(Qds) and hand grip strength were 
strongly related to aerobic power in the AS subjects. The former was selected as the 
prime candidate for the stepwise regression analysis as it is clearly more pertinent to 
the type of exercise under consideration, i.e. cycle ergometry.
Exercise usually involves both static and dynamic contractions.^ The former 
type is measured by an isometric dynamometer, as used in this study. The latter can be 
assessed by an isokinetic dynamometer, which enables the control of angular velocity 
of the moving limb. While the latter type of facility has some advantages, 133fts use 
is confined within the province of few centres due to the exceptionally high cost.
No attempts were made in the present study to address the effect o f difference 
in gender on aerobic power. This was because of the relatively small number of
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subjects in each category (17 males, 8 females). It is well known that aerobic power 
is higher in the average male, largely due to a higher percentage o f fatty tissue in the 
average female. 30
It should be mentioned that the degree of thoracic kyphosis in this study was not 
measured by radiographic means; rather, it was reflected by the wall-tragus distance. 
However, the adverse effect of thoracic kyphosis per se on aerobic power has not 
been previously confirmed.
Although restricted thoraco-lumbar mobility is physically disadvantageous, 
the degree of TL mobility, as assessed by spondylometry, did not appear to influence 
aerobic power among the AS subjects. This may be explained by the nature of cycle 
ergometry, during which the trunk is essentially immobile.
The finding of significantly higher aerobic power, after controlling for age, in 
the exercisers group underpins the importance of physical activity in patients with AS. 
On the basis of the findings in the present study, interventions aimed at improving 
peripheral muscle function would be expected to improve aerobic power and exercise 
tolerance in this condition.
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Summary of Findings
1 In line with the findings in the previous study (chapter 4), aerobic power was 
commonly reduced in the 25 patients with ankylosing spondylitis (AS).
2 Aerobic power in the AS subjects was mostly influenced by peripheral muscle 
strength, thus elaborating the findings in the previous studies. This finding 
strongly suggests that strategies to improve peripheral muscle strength would 
modify aerobic power in this condition.
3 Vital capacity and limited chest expansion influenced aerobic power only weakly 
in the AS subjects. The findings concur with the view that the diaphragm com­
pensates well for the work of breathing in AS.
4 When taking into account the peripheral muscle strength, lean body mass further 
improved the prediction of aerobic power in AS.
5 The extent o f thoracic kyphosis and the degree of thoraco-lumbar mobility did not 
appear to exert a significant influence on aerobic power in AS.
6 Aerobic power was significantly higher in the group classed as regular exercisers, 
thereby emphasising the importance of physical activity in patients with AS.
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Figure 5.1 Schematic illustration o f  the experimental set-up fo r  the 
measurement o f  maximum isometric contraction o f  the 
quadriceps (Qds). X  denotes the distance between the 
centre o f  force and the fulcrum o f  the knee joint.
Qds = Maximum force x X  ( Newton-metre ).
( Modified from reference 125 )
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Measured VCLmax 
(ml-kg-l-min-1) n=25
Qds (N-m)
V02max (ml kg"l-min"') = 14.7 + 0.10 Qds (N-m) 
[ adj.R2 46.9 %, F 22.16, p < 0.001 ]
Figure 5.2 Linear regression ofV02m ax on the force o f  maximum isometric 
contraction o f  the knee extensors (Qds) in 25 AS patients.
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Figure 5.3 Normal plot o f  Residuals from the regression m odel: 
V0 2 max (ml-kg~ 1 - min~ >) = 27.8 + 0.17
( derived from 25 subjects with ankylosing spondylitis ).
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Figure 5.4 Scattergram o f  Residuals vs Fitted VC)2 mcix from the m odel: 
V02max (ml-kg~ ^  ■ min~ 1 )  = 27.8 + 0.17 Qds (N-m)
-0 .39  LEM (kg)
( derived from 25 subjects with ankylosing spondylitis ).
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Measured VC^max 
(ml-kg-l-min-1)
40 n=25
r=0.86
p<0.001
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Fitted VC^max 
(ml-kg-l-min-l)
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Figure 5.5 Linear correlation between Measured vs Fitted V02max , 
from the regression m odel:
V02max (ml- kg~ 1-min~ 1) = 27.8 + 0.17 Qds (N-m)
-0 .39  LBM(kg)
The straight line represents the line o f  identity.
( derived from 25 subjects with ankylosing spondylitis ).
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Table 5.1
Clinical characteristics of 25 AS subjects
(17 males, 8 females; 15 exercisers, 10 non-exercisers)
Mean SD Range
A g e , yr 46.7 12.1 2 2 -6 7
H eight, m 1.66 0.08 1.47-1.80
L B M , kg 51.66 11.42 27.73 - 80.90
VC^max, ml kg"l -min"l 26.06 6.60 17.05 - 39.80
V0 2 max, % predicted 75 17.6 4 8 -1 1 0
V C , L 3.66 0.98 2 .14-5 .40
M IP , cmH20 83.6 31.0 37 - 148
T lim , s 130 116 30 - 460
Chest expansion, cm 2.02 0.71 0 .6 -3 .0
Q d s, N-m 110 44.9 29 - 186
Hand grip strength , kgW 35.3 11.73 14 - 55.5
Spondylometry, ° 51 17.7 2 0 - 8 6
Wall-tragus distance, cm 16.9 6.1 9.5 - 33
E S R , mm l sth r l . 19 14.4 1 -5 8
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Table 5.2
Stepwise regression o f  V 02m ax on Qds and LBM
Predictor Coefficient Stdev t-ratio P
Constant 27.804 3.281 8.48 <0.001
Qds 0.169 0.0208 8.14 <0.001
LBM -0.396 0.0821 -4.83 <0.001
Analysis o f variance :
Source of 
variation
Degree of 
freedom
Sum of 
squares
Mean
squares
P
Regression 
on Qds
1 512.54 512.54 <0.001
Addition of 
LBM
1 273.67 273.67 <0.001
Residual 22 258.34 11.74
Total 24 1044.55
Residual SD = Vl 1.74 = 3.42 ml kg'l-m in‘ 1, F = 33.48. 
Regression m odel :
V02max (m lkg"l-min"l) = 27.8 + 0.17 Qds (N-m) - 0.39 LBM (kg)
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Chapter 6 
Conclusions and Future Directions
The series of studies comprising this thesis have attempted to answer the ques­
tions posed in the first chapter regarding the factors influencing aerobic power and 
the mechanism (s) underlying exercise limitation among patients with ankylosing 
spondylitis (AS). In the following pages, the results of the foregoing studies will be 
pulled together and interpreted in the light of other recent studies in this field. Also, 
suggestions for further areas of study will be made. Before summarising the findings 
o f importance in individual studies, several points require comment.
As indicated earlier in this thesis, the studied patients came from a tertiary, 
referral centre. This has inevitably resulted in a study of patients with more severe AS 
than would be claimed representative of a standard AS population. This is evident by 
a mean chest expansion of 2.0 cm and a narrow standard deviation o f 0.7 cm. The 
results and clinical implications arising from the current studies therefore apply 
principally to patients with well established, moderately advanced disease.
With respect to the use of the term maximal aerobic uptake, it is defined as the 
highest oxygen uptake the individual can attain during exercise while breathing air at 
sea level.30 To fit this definition, a plateau in the oxygen uptake during exercise has 
to be reached. However, this is not usually achieved since the subjects may cease 
exercising owing to various symptoms or external stimuli or, in some instances, poor
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motivation. Therefore, the term maximal oxygen uptake (VC^max) in this thesis 
refers to the highest oxygen uptake achieved during exercise to symptom limitation.
No claim should be made that aerobic power equates exercise power. Indeed, 
anaerobic processes play an increasingly greater role as the severity of exercise in­
creases. Anaerobic power is indicative of a kind of work important in many common 
tasks. Although tests for measurement of anaerobic power have been described, 134- 
135 their clinical applications have been limited in view of the relative complexity of 
the methods. Aerobic power, on the other hand, can be measured relatively easily 
during exercise on a treadmill or cycle ergometer.
Since there is a lack of similar tool for direct measurement o f anaerobic power, 
some sort o f indirect means have to be applied when evaluating exercise power. Anae­
robic threshold (AT), as employed in chapter 4, is one of such methods. The concept 
of AT is based on an exponential rise in blood lactate concentration when exceeding a 
certain rate o f exercise/oxygen uptake. As outlined in chapter 1.3, AT can be detected 
by measuring blood lactate level or noninvasively by detecting a breaking point of pul­
monary ventilation versus oxygen uptake. However, it is sometimes difficult to esta­
blish a well-defined 'point'. The work rate at which a nonlinear increase in ventilation 
occurs need not be the same exercise rate at which the lactate concentration r i s e s . 30 
Furthermore, there are individual variations in the highest lactate level which can be 
tolerated during prolonged exercise. 136 Nonetheless, AT provides important informa­
tion as regards the individual's aerobic potential, and about the effect of training. The 
threshold concept, as such, however, rests on an unstable foundation.
The studies comprising this thesis commenced in C hapter 2 with measurements
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of the symptom of breathlessness, which is important in any studies such as these.
The results are in contrast with the prevailing concept that AS patients rarely suffer 
from exertional dyspnoea. The subjects who took regular exercise experienced undue 
breathlessness less commonly than the non-exercisers. The finding of a greater 
magnitude of dyspnoea perceived during everyday activities among the AS patients in 
the oxygen cost diagram study substantiates the main finding from the initial survey. 
The findings thus confirmed the presence of perceived exertional dyspnoea among AS 
patients in subjective as well as numerical terms, and indicated the need for the 
subsequent physiological studies.
C hapter 3 examined the performance of the respiratory muscles in AS both in 
terms of maximal strength and endurance. The study provides no strong evidence that 
respiratory muscle strength, as indicated by maximal respiratory pressures, is reduced 
in AS. However, the inefficiency of the respiratory muscles in the AS patients became 
evident during sustained breathing at high inspiratory pressures. Furthermore, the ele­
vated resting lung position adopted by the AS patients appeared to adversely affect 
respiratory muscle performance during work requiring high inspiratory pressures. The 
finding of impaired respiratory muscle endurance (RME) posed a crucial question as 
to its clinical significance in AS and called for the subsequent investigation into the 
possible role o f impaired RME on exercise tolerance in this condition.
In C hapter 4 attention was paid to a comprehensive assessment of exercise 
tolerance in AS. Furthermore, attempts were made to examine the possible link bet­
ween exertional dyspnoea in AS, as evident from the studies in chapter 2, and altered 
lung subdivisions and chest restriction commonly found in this condition. Several
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important findings emerged from this study. In agreement with the few previous 
studies,40,41 effort tolerance and work capacity were substantially curtailed in the 
AS patients. The finding of a greater degree of leg fatigue perceived among the AS 
subjects suggested that musculoskeletal deconditioning was the main factor limiting 
exercise in the AS group.
While a comparatively higher ventilatory response to exercise was observed in 
the AS group, as compared with the controls, their Vj?max/ VCO2  values were still 
within normal range. Furthermore, their breathing reserve remained adequate and no 
major gas exchange abnormality was found.
Although heart rate response to exercise in the AS group was raised, other car- 
diocirculatory variables were appropriate to exercise level. The findings were com­
patible with an element of cardiac deconditioning consequent to a relative lack of 
physical activity rather than cardiac disease. The interpretation of the findings 
thus agreed with the aforementioned view that peripheral deconditioning was the main 
factor causing exercise intolerance in the AS subjects.
The severity of breathing effort at an equivalent work rate or ventilation was 
found to be greater among the AS subjects, thus corroborating the findings in chapter 2 
with respect to exertional dyspnoea. However, the magnitude of exertional dyspnoea 
was not related to impaired resting lung volumes or the degree of chest restriction, in­
dicating that the three variables represent separate quantities which characterise the 
condition of patients with AS.
Another prominent finding emerged was the lower mean anaerobic threshold in 
the AS group, as compared with that of controls. This finding implies a relative lack
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of aerobic fitness among the AS subjects. Furthermore, the resultant lactic acid 
accumulation may in part account for the greater degree of leg fatigue perceived among 
the AS subjects. However, in the absence o f direct measurement o f blood lactic acid 
the interpretation of this finding is speculative.
Apposite to the findings in chapter 4 is the findings from a recent study by 
Calin e ta lA ^7 in part of the study, the investigators followed a random cohort of 
60 AS patients over a 2-week period and found that fatigue was the main symptom in 
over 50 % of the subjects. The authors concluded that fatigue should be considered 
a major problem for patients with AS, worthy of further exploration in terms of both 
aetiology and therapy.
The results in chapters 3 and 4 suggested that peripheral muscles and/or respi­
ratory muscles play an important role in reduction in aerobic power in AS. The final 
study in C hapter 5 therefore attempted to quantitively determine the contribution of 
these factors to aerobic power in AS. The finding of a major influence of peripheral 
muscle strength on aerobic power in the AS subjects elaborated the results in chapter 4.
Little attention has focused on peripheral muscle function in AS. Based on 
limited available information, convincing evidence of involvement o f skeletal muscles 
in AS is lacking.79 Peripheral muscle deconditioning in AS therefore appears to 
result from disuse consequent to the chronic nature of the disease.
The finding of a weak influence of limited chest expansion on aerobic power 
in AS may be accounted for by the diaphragmatic compensation in this condition. A 
similar explanation may apply to the weak relationship between aerobic power and 
vital capacity.
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Impaired respiratory muscle endurance did not appear to play a significant role 
in exercise intolerance in the AS subjects. Possible explanations for the lack of asso­
ciation between aerobic power and RME were given in the discussion in chapter 5.4.
Perceived exertional dyspnoea among AS patients is one of the issues addressed 
in this thesis. Although undue breathlessness was confirmed in chapter 2, various 
cardiorespiratory abnormalities did not account for exercise limitation in subsequent 
physiological studies. The undue breathlessness is therefore best interpreted as normal 
" physiological" breathlessness which is one component o f perceived exertion and can 
be prominent in deconditioned patients.
A variety of deficits in lung function and exercise mobility are demonstrated in 
this thesis. However, it is not the deficits in lung function which are the cause of the 
loss o f mobility but rather the vicious cycle of deconditioning which affects peripheral 
muscle thereby promoting gradual loss of mobility. The common assumption that 
breathlessness limits exercise performance where there are deficits in thoracic wall 
excursion is potentially unhelpful as it can deflect clinicians away from potentially 
effective musculo-skeletal rehabilitation.
Based on the results of the present studies, assessment o f peripheral muscle 
function should form an important element in rehabilitation programme for AS patients. 
The findings suggest that strategies aimed at maintaining/improving peripheral muscle 
function are potentially beneficial to sufferers from this condition.
Peripheral muscle training, for example weight lifting, has been found valuable 
for improving exercise tolerance in patients with coronary artery disease ^ ^ a n d  chro­
nic airflow limitation. 139 More recently, isolated exercise of specific muscle groups
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(sequential muscle training) has been shown to improve muscle conditioning and 
tolerance of steady state submaximal exercise in patients with chronic obstructive 
airway disease.
Ankylosing spondylitis is heterogeneous with patients across a wide range of 
severity of skeletal restriction. Recommendations upon effective rehabilitation 
options must be based on the type of patients being considered. It is nevertheless 
not a disadvantage of the current studies to have looked at patients with moderately 
advanced stage of AS. The results are also very likely to apply to those with milder 
end of the spectrum who may benefit most from improvement in mobility through 
systematic application of muscle conditioning.
However, patients with the most advanced chest restriction and ventilatory 
limitation may require different strategies for treatment other than simple peripheral 
muscle conditioning. Such a population may demonstrate an amplified reduction 
in repiratory muscle function and may benefit from respiratory muscle training.
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ABBREVIATIONS
R esp ira to ry  v a riab les
BR
BTPS
DLco
f
FEVi
FRC
FRC / TLC
15-sMVV
P(A-a)02
Palv
Pa02
PaC02
pH
Pm
R
Raw
RV
R V /T L C
STPD
tcP 02
Breathing reserve
Body temperature and pressure, saturated with water vapour 
Diffusing capacity of the lungs for carbon monoxide 
Breathing frequency 
Forced expiratory volume in one second 
Functional residual capacity
Functional residual capacity as a proportion of total lung capacity
Maximal voluntary ventilation
Alveolar-arterial oxygen pressure difference
Alveolar pressure
Partial pressure of arterial oxygen
Partial pressure of arterial carbon dioxide
Blood pH value
Mouth pressure
Respiratory exchange ratio
Airways resistance
Residual volume
Residual volume as a proportion of total lung capacity 
Standard temperature and pressure, dry 
Transcutaneous oxygen pressure
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tcPCC>2 Transcutaneous carbon dioxide pressure
Ti Inspiratory duration
TLC Total lung capacity
Him Respiratory muscle endurance time
Ttot Duration of a complete breath
Ti / Ttot Duty cycle, or inspiratory duration as a proportion of a total breath
VC Vital capacity
V C 02 Carbon dioxide production per minute (STPD)
VD /V T Physiological dead space-tidal volume ratio
VE Expired minute ventilation (BTPS)
AVE /A V C 02 Ventilatory response to exercise
V 0 2 Oxygen uptake per minute (STPD)
V02max Symptom-limited maximum oxygen uptake
Haemodynamic variables
AT Anaerobic threshold
BPdias Diastolic blood pressure
BPsys Systolic blood pressure
ECG Electrocardiograph
HR Heart rate
AHR/AVO 2 Heart rate response to exercise
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Statistical notations
95 % Cl 95 % confidence interval
SD Standard deviation
SEM Standard error o f mean
Other variables
AS Ankylosing spondylitis
BS Breathlessness score ( modified Borg scale)
CPX Cardiopulmonary exercise
LBM Lean body mass
LS Leg fatigue score ( modified Borg scale )
Qds Force of the maximum voluntary contraction of the quadriceps
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APPENDIX A
Screening questionna ire  fo r AS s tudy  (G R I, 1993) Date of interview 
........................................................  Date of birth  / ...... /....Name
Address
Occupation
Instructions : Please tick the appropriate box, or write in the space provided 
when indicated.
1. For how long have you suffered from ankylosing spondylitis ? ......
2. What is the level of physical activity involved in your job or daily life ?
.years.
3. Do you regularly take exercise or play sport ?
Light
Moderate
Strenuous
Yes
No
if"  Yes " Please give details :
Type of exercise or sport 1 , approximately........ hours/week.
 2.................................  approximately......... hours/week.
 3 , approximately.........hours/week.
4. Do you ever get short o f breath when walking with 
others of your own age, on level ground ?
5. Do you usually cough first thing in the morning ?
Yes
No
Yes
No
6. Do you usually cough like this on most days for as much as 
three months each year ?
7. Do you usually bring up spit or phlegm first thing in the morning ?
Yes
No
Yes
No
142
8. Do you usually bring up spit like this on most days for as much as 
three months each year ?
9. Do you smoke ?
10. How many cigarettes/cigars do you smoke per day ? ......
11. How long have you smoked ? ......
12. If  you have ever smoked,
a. How long did you smoke for ?...... ........
Yes
No
Yes
No
.per day 
 years.
.years.
b. How many did you smoke per d a y ........
c. When did you stop ?
a. Heart trouble □
b. Bronchitis □
c. Asthma □
d. Pneumonia / Pleurisy □
e. Tuberculosis □
f. Other chest illnesses, please give details
14. Do you require regular medicines for any condition ?
i f " Yes " please give details : a. What is the condition ? ....
b. What are the medicines?..
15. Do you think you get tired more easily than other people ?
16. Has your physical fitness changed much in the past 5 years ? 
i f " Yes " ,  please indicate if  your fitness is worse or improved
Yes
No
Yes
No
Yes
No
worse
improved
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APPENDIX B
Presentations at scientific m eetings on the studies relating to this thesis.
1. Influence of Altered Lung Subdivisions on Respiratory Muscle Performance in 
Patients with Ankylosing Spondylitis.
P Riantawan. R Carter, R D Sturrock, S W Banham 
Oral presentations and discussions at the
1 Scottish Rheumatology Club meeting, Glasgow, 28/ 05/ 94.
2 Scottish Thoracic Society summer meeting, Perth, 24/ 06/ 94.
Poster presentations at the
1 European Respiratory Society annual congress, Nice, France,4/10/94.
2 British Society for Rheumatology Heberden round, Bath, 22/09/94.
2. Factors Influencing Aerobic Power in Patients with Ankylosing Spondylitis.
P Riantawan. R Carter, R D Sturrock, S W Banham
Poster presentation and oral discussion at the
British Thoracic Society summer meeting, Manchester, 1/ 07/ 94.
3. Exercise Limitation in Patients with Ankylosing Spondylitis 
P Riantawan. R Carter, R D Sturrock, S W Banham 
Poster presentation at the
European Respiratory Society annual congress, Nice, France, 4/10/94.
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